Next Article in Journal
Gryllus bimaculatus Hydrolysate Ameliorates Obesity-Induced Muscle Atrophy by Activating Skeletal Muscle AMPK in Mice
Previous Article in Journal
A Nationwide Survey of Italian University Students: Exploring the Influences of Sustainable Dietary Behaviors, Lifestyle, and Sociodemographic Factors on Adherence to the Mediterranean Diet
Previous Article in Special Issue
Sex-Dependent Gut Microbiota Features and Functional Signatures in Metabolic Disfunction-Associated Steatotic Liver Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Fermented Fruits, Vegetables, and Legumes in Metabolic Syndrome: From Traditional Use to Functional Foods and Medical Applications

by
Karolina Bernacka
1,*,
Tomasz Sozański
2 and
Alicja Z. Kucharska
1
1
Department of Fruit, Vegetable and Plant Nutraceutical Technology, Wrocław University of Environmental and Life Sciences, Chełmońskiego 37, 51-630 Wrocław, Poland
2
Department of Preclinical Sciences, Pharmacology and Medical Diagnostics, Wrocław University of Science and Technology, Hoene-Wrońskiego 13 c, 58-376 Wrocław, Poland
*
Author to whom correspondence should be addressed.
Nutrients 2025, 17(12), 1989; https://doi.org/10.3390/nu17121989
Submission received: 7 May 2025 / Revised: 6 June 2025 / Accepted: 9 June 2025 / Published: 12 June 2025

Abstract

:
Fermentation has been used for centuries to preserve food and to obtain products with new, attractive sensory characteristics. Fermented products are a source of dietary fiber, vitamins, bioactive compounds, and probiotic bacteria with health-promoting properties. This review provides a comprehensive overview of the effects of fermented fruits, vegetables, and legumes on metabolic disturbances characterizing metabolic syndrome (MetS). Furthermore, the chemical composition, microbial communities, and molecular mechanisms of action of fermented plant foods are discussed. Fermented fruits and vegetables, including table olives, caper fruits, and kimchi, contain polyphenols and probiotic bacteria, which are beneficial in terms of obesity and impaired glucose and lipid metabolism. Fermented legumes are a valuable source of bioactive peptides and isoflavone aglycones. Among fermented soybean products, natto stands out due to the presence of γ-polyglutamic acid, which improves glucose tolerance and the lipid profile, and nattokinase, an enzyme that acts as an angiotensin-converting enzyme inhibitor. Potential future studies focused on developing functional fermented foods and easy-to-use supplements based on fermented plant products are suggested.

Graphical Abstract

1. Introduction

Metabolic syndrome (MetS) is a cluster of comorbid metabolic disorders that include visceral adiposity, atherogenic dyslipidemia, insulin resistance, and hypertension. Untreated MetS is associated with an increased risk of diabetes and cardiovascular disease (CVD), the main cause of death worldwide [1]. Today, MetS is also known to be associated with a higher risk of non-alcoholic fatty liver disease, neurodegenerative diseases, cancer, and gut microbial dysbiosis [2,3].
All dysregulations included in the MetS definition are strongly related to lifestyle. Some modifiable factors, such as an imbalance between energy intake and expenditure, unhealthy dietary patterns, sedentary lifestyle, poor sleeping habits, and stress, underlie metabolic disturbances [4]. The prevention and incidence of MetS are associated strongly with dietary habits. One of the most beneficial dietary patterns in MetS prevention and treatment is the Mediterranean diet, which is characterized by a high intake of plant-based foods: fruits and vegetables, together with olive oil, whole grains, legumes, and nuts [2].
Plant food contains a wide range of bioactive compounds, including polyphenols, vitamins, phytosterols, biogenic amines, and biologically active proteins, which are beneficial to human health [5]. In many cultures, some plant raw materials undergo fermentation to obtain desirable organoleptic attributes (such as flavor, smell, and texture) and an extended shelf life [6,7,8]. Fermentation is considered to be a process that can affect bioactive compounds both favorably and adversely [9]. Biologically active compounds, such as betalains, may degrade during fermentation. However, the breakdown of complex phenolic compounds can lead to the formation of simpler molecules (e.g., aglycones), which are often characterized by higher bioactivity [9].
During the fermentation, a breakdown of plant cell walls occurs, which promotes the liberation of phytocompounds. Degradation of complex polyphenols leads to an increase in total phenolic content (TPC) [10] and, consequently, an increase in the antioxidant capacity of the products [11]. During fermentation, the counteraction of toxic, anti-nutritive, and allergenic compounds takes place, which is particularly significant in the processing of legumes [12,13]. Fermented plant-based foods also contain microorganisms, including probiotic bacteria. Among probiotic bacteria, an important group occurring in fermented foods is lactic acid bacteria (LAB), which is responsible for lactic fermentation in kimchi, sauerkraut, table olives, and many others [6]. As a consequence of fermentation in fermented food, metabolites called ‘postbiotics’ occur [14]. In many cases, fermentation leads to an increase in vitamins (such as thiamine, riboflavin, cobalamin, and folic acid) [6], antioxidant polysaccharides, and antioxidant peptides, which originate from microbial hydrolysis and biotransformation [9].
This work discusses the potential use of fermented fruits, vegetables, and legumes as functional foods that can be applied in the prevention and alleviation of metabolic disturbances. It primarily focuses on the health-promoting properties in the context of MetS, as well as on the bioactive compounds and microbial communities of fermented foods. Furthermore, it discusses the potential mechanisms of the favorable effects of fermented products, their constituents, and the probiotics included in them on metabolic health. Finally, we present an overview of the recent trends in fermentation and future perspectives for the application of fermented fruits, vegetables, and legumes in MetS management.

2. Selection of Relevant Publications

A literature search was performed manually in the Google Scholar, Scopus, and PubMed databases, with a combination of “metabolic syndrome”, “diabetes”, “lipid profile”, “microbial community”, “chemical composition”, and product names such as “kimchi”, “sauerkraut”, “table olives”, “natto”, and others. The review included papers from the last 10 years, as well as papers published before that period that concerned animal or human studies. Because the nomenclature of bacteria has changed in the last few years, in the case of papers that use the old names, the updated nomenclature is given in parentheses.

3. Fermentation

Fermentation is defined as a process in which the metabolic activity and growth of bacteria, yeasts, and molds are used to preserve food. During fermentation, microorganisms convert carbohydrates into simpler substances such as carbon dioxide, alcohol, organic acids, and other compounds [6]. Fermentation can be classified according to the technology, type of microorganisms carrying out the fermentation, and product profile (acidic, alkalic, or alcoholic) (Figure 1). According to technology, fermentation can be divided into spontaneous fermentation, fermentation with starter cultures, and back-slopping. Traditional (spontaneous) fermentation occurs in rural regions and is still applied in industry for some products, such as sauerkraut. The microbiota in spontaneous fermentation depends on microorganisms present in raw products, the environment, and equipment. Another characteristic feature of the spontaneous process is the succession of microorganisms. LAB usually occur in the primary stage of fermentation. In the final stage of fermentation, the number of LAB decreases and yeast appears. Yeast may form a white film on the surface of the product, which is associated with a deterioration of its quality [8,15,16,17]. A more predictable type of fermentation technology is back-slopping, where a portion of a product from a previously fermented product is used to inoculate a new batch. Nowadays, the most favorable method seems to be controlled fermentation with selected starter cultures (containing one or several strains) [8]. Controlled fermentation provides a short time of fermentation, reduction in spoilage, and high safety, and allows one to obtain a product with desirable organoleptic or probiotic properties [8,15].
The profile of fermented food is related to the microbial communities. One of the most common groups of bacteria carrying out the fermentation is LAB. LAB are non-spore-forming, nonaerobic, or aerotolerant, Gram-positive bacteria that conduct the fermentation of sugar to lactic acid, which is the major end-product of the fermentation. LAB possess a GRAS status (Generally Recognized as Safe), which allows their use as probiotics and starter strains [18]. Pickles produced by lactic acid fermentation are characterized by a low pH (acidic profile) and sour taste. The most popular lactic acid-fermented foods are sauerkraut, kimchi, and table olives [19].
Legumes and legume-based Asian and African products are mostly fermented by Bacillus. Bacillus is an aerobic, Gram-positive, heat-resistant, and spore-forming bacterium [20,21]. The most dominant Bacillus species occurring in fermented food is Bacillus subtilis, which, as a LAB, possesses the GRAS status. Bacillus shows proteolytic, amylolytic, and lipolytic activities. In the first stage of fermentation, Bacillus ferments carbohydrates to acids, and the pH slightly rises. This is followed by proteolysis by bacterial enzymes. Proteolysis leads to the production of alkaline compounds (ammonia and amines) through peptides and amino acids, which consequently leads to an increase in pH to about 8–10 (alkaline profile) [20,22]. Moreover, some Bacillus species produce an amino acid polymer, which gives a characteristic sticky texture to the fermented products [19].
Yeast is also involved in the fermentation of vegetables and legumes, although they play a secondary role. Yeasts convert sugar into alcohol, limit the growth of mycotoxin-producing molds, and exhibit enzymatic activity. In LAB-fermented foods, yeast enzymes break down the phenolic compounds responsible for inhibiting the growth of LAB. Products with an alcoholic fermentation profile, mainly conducted by yeast, include alcoholic beverages (beer, wine, vodka) and sourdough [21,22].
Some fermented foods and beverages are made with the participation of filamentous molds. Molds are characterized by their ability to produce enzymes (α-amylase, β-galactosidase, cellulase, hemicellulose, and lipases) and degrade anti-nutritional compounds. An example of a food obtained by mold fermentation is Rhizopus-fermented soybeans [19,21].

4. Fermented Fruits

The chemical composition, microbial communities, and health benefits of selected fermented fruits are presented below.

4.1. Table Olives

Table olives are fermented fruits of the olive tree (Olea europaea L.). Olives and olive oil are historically a component of the diet of people living in the Mediterranean regions. In 2010, olives were added to the Mediterranean Diet Healthy Eating Pyramid as a product that should be consumed on a daily basis due to its content of biologically active compounds, fatty acids (FA), and dietary fiber [23,24]. The production of table olives is constantly increasing. Currently, the main table olive producers are Mediterranean countries (Italy, Greece, Spain, and Portugal), as well as Turkey, Egypt, Syria, and Morocco [24]. To obtain an edible product from a bitter drupe, three main ways of processing are applied. They are called ‘Greek natural’, ‘green Spanish’, and ‘California-style black ripe’ methods.
  • Greek olives are harvested in the purple stage of maturation, debittered by long soaking in brine (up to 1 year), and then fermented. To correct the color losses caused by the diffusion of anthocyanins, ferrous gluconate can be added. The final product is characterized by a sour, fermented, and salty flavor and a low pH (~4).
  • Green Spanish olives are harvested in a green stage of maturation, debittered by lye treatment, and fermented in brine for up to 7 months. The ready-to-go product remains green and has a sensory profile and pH similar to natural Greek olives.
  • California-style olives are obtained by an artificial method. First, the olives in a green stage of maturation undergo a debittering process by lye treatment. To obtain a black-colored product, the fruit is then oxidized by air. Lye treatment and oxidation are repeated several times, and then ferrous gluconate is added to fix the black color of the olives. The debittering process lasts only one week, and the fermentation process is omitted. The final product is characterized by an earthy, soapy, and buttery taste, a high pH (5.8–7.9), and may contain acrylamide.
As this review is focused on fermented products, in the following paragraphs, California-style olives are omitted [25].

4.1.1. Nutrients and Phytocompounds

The crucial macronutrients in table olives are lipids. The amount of total fat in olives reaches values of up to 28 g/100 g of the edible portion. The most prevalent fatty acid is oleic acid, a monounsaturated fatty acid (MUFA). Olives are also a source of sterols (20–30 mg/100 g of edible portion) and fatty alcohols [24]. The bioactive compounds present in table olive fruits are secoiridoids (oleuropein, ligstroside) and phenolic compounds, including phenolic alcohols (tyrosol, hydroxytyrosol), flavonols (rutin), flavones (luteolin, apigenin glycosides), a hydroxycinnamic acid derivative (verbascoside), lignans (pinoresinol), and phenolic acids [26]. Olives also contain non-phenolic compounds belonging to triterpenic acids. The detailed chemical composition of table olives is presented in Table 1.
During fermentation, the amount of oleuropein decreases. Bacterial hydrolysis of oleuropein occurs in two steps. First, β-glucosidase, produced by bacteria, such as Lactobacillus pentosus (currently Lactiplantibacillus pentosus), hydrolyzes oleuropein to glucose and aglycone. The aglycone is transformed to elenolic acid and hydroxytyrosol by an esterase, another enzyme produced by LAB [23,61]. As a result, the content of hydroxytyrosol (HT) rose from 273.43 μg/g fresh tissue in fresh olives to 367.83 or 333.96 μg/g in Greek-style and Spanish-style olives, respectively [62]. The bitter compounds present in olives can also be hydrolyzed by lye treatment. Lye penetrates the flesh and hydrolyzes oleuropein and ligstroside to non-bitter compounds such as tyrosol and HT [26]. The content of bioactive compounds is closely related to the manner of olive processing. Greek-style olives contain more phenolic compounds than Spanish-style olives [63].

4.1.2. Microbiota

Fermented olives contain numerous LAB species, including Lactobacillus, Leuconostoc, Lactococcus, Streptococcus, Pediococcus, Weissella, and Enterococcus [23,27,28,29,30]. The most frequent species in olives are Lactobacillus plantarum (currently Lactiplantibacillus plantarum) and L. pentosus, followed by Lactobacillus brevis (currently Levilactobacillus brevis), Lactobacillus coryniformis (currently Loigolactobacillus coryniformis), Lactobacillus paraplantarum (currently Lactobacillus paraplantarum), and Leuconostoc mesenteroides [27]. The bacterial community can be affected by lye treatment. Lye can influence the bacteria present both in the brine and on the surface of the fruit and inhibit desirable bacterial growth by pH changes [64]. On the other hand, water-rinsing following lye treatment enables the removal of oleuropein and some phenolic compounds, which limit LAB growth [25]. Apart from LAB, yeasts are important for olive fermentation. Yeasts promote the degradation of some phenolic compounds, which inhibit LAB growth [27]. The detailed characteristics of the microbial community of table olives are shown in Table 1.
Despite the numerous advantages of using starter strains, olives are still produced by spontaneous fermentation. In the case of olives, the use of starter strains may have additional benefits because some strains may produce β-glucosidase, which is related to oleuropein degradation and, as a consequence, lower bitterness [27,65,66]. The debittering effect can also be achieved by using a combined starter culture, including LAB (L. plantarum) and yeasts (Saccharomyces cerevisiae) [67].

4.1.3. The Relevance of Table Olives in the Context of MetS

Oleuropein, which is considered the most pro-health compound in fresh olives, undergoes hydrolysis to HT during fruit ripening, olive processing, and storage. After ingestion, the remaining amount of oleuropein undergoes hydrolysis to HT by enzymes produced by gut microbiota [68]. As a result, HT remains the most important compound responsible for the health benefits of table olives. It is worth noting that the amount of HT in table olives (2–114 mg/100 g) [24] is higher than that in olive oil (5–20 mg/100 g) [68]. HT has been thoroughly studied in terms of its aging, neurodegenerative diseases, metabolic disorders, and CVD [68]. The EFSA [69] claimed that 5 mg of HT and its derivatives (such as tyrosol and oleuropein) should be consumed daily to reduce oxidative stress and protect LDL from oxidative damage. Although the meta-analysis conducted by Pastor et al. [70] found that HT had no effect on MetS, HT supplementation could affect the antioxidant capacity components associated with MetS. Some clinical trials involving patients with metabolic disturbances have shown that HT supplementation (5–9.7 mg/day) could improve insulin sensitivity, blood pressure (BP), and lipid profile [71,72,73]. HT administration (9.3 mg/g) for 8 weeks reduced LDL, oxidized LDL, total cholesterol, triglycerides (TG), and apolipoprotein B (ApoB) in MetS patients [71]. In vitro studies confirmed that HT can regulate lipid metabolism by activating AMP-activated protein kinase (AMPK) and decreasing the enzymatic activity of acetyl-CoA carboxylase (ACC), diacylglycerol acyltransferase (DGAT), and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR) [74]. In 3T3-L1 adipocytes, HT upregulates the expression of carnitine palmitoyltransferase 1 (CPT-1) and peroxisome proliferator-activated receptor α and γ genes (PPAR-α and PPAR-γ). Moreover, it effectively stimulates mitochondrial biogenesis and mtDNA quantity, affects mitochondrial function, and lowers free fatty acid (FFA) levels in adipocytes. This action could explain the hypolipemic and insulin-sensitizing effect of HT [75].
To the best of our knowledge, no research has been conducted on the potential of table olives as a food that could alleviate MetS. However, due to its chemical composition, which is determined by both the biologically active compounds contained in the raw fruits and those formed as a result of the fermentation process, table olives could be considered a potential superfood for improving metabolic disturbances. Further investigation is needed to determine the impact of table olives consumption on MetS components.

4.2. Capers

The caper (Capparis spinosa) is known as a medicinal plant in Iranian Traditional Medicine. Pickled caper buds and berries are edible products and are produced mainly in Mediterranean countries. Although fresh caper fruits used to be consumed by elderly Iranian and Bahrainis, the consumption of raw caper berries is not popular due to their bitter taste caused by the presence of the glucosinolate glucocaparin. To eliminate bitterness, caper buds and berries undergo spontaneous lactic acid fermentation in brine or a mixture of brine and vinegar. Fermented caper buds are appreciated for their distinctive sensory attributes, including their characteristic flavor and texture [31,76,77,78].

4.2.1. Nutrients and Phytocompounds

The main phytocompounds in fermented caper buds are flavonols, mainly kaempferol-3-O-rutinoside (409.85 mg/100 g dry weight (DW)) and quercetin-3-O-rutinoside (rutin) (316.35 mg/100 g DW) (Table 1). These flavonols also occur in caper berries, but their content is much lower (1.66 and 12.12 mg/100 g, respectively) [31]. Brine-fermented caper fruits also contain FA (mainly linoleic, oleic, and palmitic) [79] and phenolic acids (including ferulic acid, gallic acid, and protocatechuic acids) [31,32,79]. Glucosinolates present in raw berries are fully degraded during fermentation [76]. Caper fruits are also a good source of some minerals, including potassium (994.25 mg/100 g fruits), calcium (327.72 mg/100 g), and magnesium (109.32 mg/100 g) [79].

4.2.2. Microbiota

The bacterial community of caper fruits includes LAB (Lactobacillus, Pediococcus) and Enterococcus faecium. The predominant species of bacteria is L. plantarum [80]. The only yeast species identified in caper pickles is Aureobasidium pullulans (Table 1) [33]. There were attempts to obtain pickled caper berries with a starter strain (L. pentosus OM13). The use of a starter strain seems promising because the product is characterized by a low bitterness and high hardness [33]. To the best of our knowledge, there is a lack of precise information about microbiota in fermented caper buds. Ózcan et al. [81] reported that the LAB group occurs in fermented bud brine during 10–20 days of fermentation. The quantity of LAB depends on the bud size and is higher in small ones [81].

4.2.3. The Relevance of Capers in the Context of MetS

Although fermented capers, compared to raw ones, have a higher TPC and total flavonoid content, stronger antioxidant properties, and are a source of probiotic bacteria, there are few studies on their health-promoting properties [76,80]. Two clinical studies confirmed that pickled caper fruit consumption (12 weeks) could exert anti-diabetic and hypolipidemic effects in overweight and obese patients with non-alcoholic fatty liver disease (Table 2) [77,82]. Pickled caper fruits may also enhance the hypolipemic effect of statins [83]. To the best of our knowledge, no one has so far studied the metabolic properties of caper bud pickles.

5. Fermented Vegetables

The chemical composition, microbiota, and health-promoting properties of selected fermented vegetable products are summarized below.

5.1. Kimchi

Kimchi is a traditional Korean fermented dish prepared from Chinese cabbage, leeks, radishes, chives, and condiments such as ginger, garlic, red pepper powder, and salted fermented seafood (aekjeot) or fish sauce (jeotgal). Kimchi has been an integral part of Korean food culture for thousands of years, and in 2013, the communal activity of making kimchi was inscribed on UNESCO’s list of Intangible Cultural Heritage of Humanity. Kimchi has gained popularity worldwide for its health benefits. Due to the fermentation process and the selection of spices, it is characterized by a unique spicy, sour, sweet, and carbonated taste. Fermentation is conducted at low temperatures and in anaerobic environments [16,34,35,123,124].

5.1.1. Nutrients and Phytocompounds

Kimchi contains 17.9 g of protein, 2.3 g of lipids, 31.3 g of dietary fiber (both soluble and insoluble), microelements such as potassium (44.3 mg/100 g), calcium (1.5 mg/100 g), magnesium (1.7 mg/100 g), zinc (33.9 mg/100 g), and vitamins [125]. The chemical composition is determined by the range of condiments used for product preparation. The addition of red pepper is a key source of vitamin C, carotene, and capsaicin, while the addition of ginger provides anti-inflammatory phytocompounds, gingerol, and shogaol [126]. The basal kimchi ingredient, cabbage, is a source of phytoestrogens. Among them is β-sitosterol, which competes for absorption with cholesterol. Leeks, onions, garlic, and spring onions are sources of sulfur compounds. Also, kimchi cabbage contains sulfur compounds, including sulforaphane, allyl isothiocyanate, benzyl isothiocyanate, and phenyl isothiocyanate [36,126]. However, during fermentation, the amount of isothiocyanates, especially sulforaphane, decreases [127]. In fermented products, there also occur volatile sulfur compounds (allyl methyl disulfide, diallyl tetrasulfide, 4-ethyl-5-methylthiazole, allyl methyl trisulfide, 3-vinyl-[4H]-1,2-dithiin) and 2-phenylethyl isothiocyanate [128]. The relevant biologically active compound is 3-(40-hydroxyl-30,50-dimethoxyphenyl) propionic acid (HDMPPA). A study on an animal model confirmed that supplementation with HDMPPA has a beneficial impact on lipid profile (decrease of TG and LDL) and an anti-atherogenic effect [36]. The chemical composition of kimchi is presented in Table 1.

5.1.2. Microbiota

Kimchi contains a complex microbial ecosystem, including LAB (Lactobacillus, Lactococcus, Leuconostoc, Pediococcus, Tetragenococcus, and Weissella), yeasts (Candida, Kluyveromyces, Lodderomyces, Pichia, Saccharomyces, and Trichosporon), and archaea (Table 1) [16,34,35,124]. The composition of the microbial community and its metabolic profile are determined by the microbial niches in the raw ingredients [17], salt concentration [129], and the duration of fermentation [16]. The LAB present in kimchi originates mainly from vegetables, with the exception of Tetragenococcus, which comes from jeotgal [35]. Yeasts that occur during the late stage of fermentation are responsible for an undesirable white film on the surface of the product [16]. LAB originating from kimchi is responsible for the production of metabolites such as γ-aminobutyric acid (GABA), bacteriocins, ornithine, exopolysaccharides, etc. The mentioned metabolites enable them to survive in an acidic environment. Bacteriocins are proteins or peptides synthesized in bacterial ribosomes. Due to antibacterial properties, bacteriocins could be applied as natural food preservatives. They originated from kimchi LAB strains, and their stability has been summarized by Lee et al. [124]. One of the most significant metabolites is GABA, produced primarily by L. brevis [124]. Due to the multidirectional health-promoting properties of GABA, there have been attempts to increase its content in kimchi. The most effective manner seems to be inoculation by GABA-producing LAB (for instance, Lactobacillus zymae (currently Levilactobacillus zymae) GU240) and the addition of the direct GABA precursor monosodium glutamate [124]. Other important bacterial metabolites that occur in kimchi are lactic acid and acetic acid, which are responsible for the flavor and aroma of kimchi [128].

5.1.3. The Relevance of Kimchi in the Context of MetS

Kimchi consumption or supplementation with kimchi-derived probiotic strains is associated with various health-promoting effects, proven in both in vitro and animal and clinical studies (Table 2). Kimchi or kimchi LAB strains have antioxidant [36], anti-inflammatory [16,85,130], anti-obesity [16,84,85,86,130,131,132], anti-diabetic [36,84,85,86,130,133], hypotensive [86], and hypolipidemic effects [16,36,84,85,130]. In the Korean Genome and Epidemiology Study (with 10-year follow-up), frequent consumption of kimchi was correlated with a lower risk of MetS in women, while in men, kimchi consumption was not associated with MetS [134].
An et al. [86] compared the anti-diabetic, hypotensive, and anti-obesity effects of kimchi before and after fermentation. Both types of kimchi, consumed daily for 8 weeks, improved body weight, body mass index (BMI), and waist circumference (WC), but only fermented kimchi improved BP. Insulin sensitivity, measured by the Matsuda Index and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), was improved by both types of kimchi, but the Quantitative Insulin Sensitivity Check Index (QUICKI) and Disposition Index (DI) were improved only after consumption of the fermented product. It is possible to improve the health-promoting effect and production of kimchi by adding a starter culture. Consumption of fermented kimchi with Weissella koreensis OK1-6 was associated with lower serum leptin and insulin concentrations and a better lipid profile and metabolism in mice maintained on a high-fat diet. The effect after consumption of kimchi manufactured without a starter was also significant but weaker [85]. Furthermore, kimchi fermented with W. koreensis OK1-6 contains a higher amount of ornithine than spontaneously fermented kimchi (117.06 vs. 21.43 mg/100 g fresh weight). It is suggested that in addition to probiotic bacteria, ornithine could be responsible for the anti-obesity effect of kimchi [85]. Moreover, kimchi fermented with starter W. koreensis OK1-6 [85] and the probiotic strain isolated from kimchi L. brevis OPK-3 [130] modify lipid metabolism in the liver by downregulating genes related to lipid metabolism (liver X receptor alpha gene (LXRα), sterol regulatory element-binding protein 1c gene (SREBP-1c), ACC, sterol regulatory element-binding protein 2 gene (SREBP-2), PPAR-γ, fatty acid synthase gene (FAS), low-density lipoprotein receptor gene (Ldlr), 1-acyl-sn-glycerol-3-phosphate acyltransferase 5 gene (Agpat5)) and upregulating genes related to FA oxidation and lipid catabolism (Ppar-α, acyl-CoA oxidase gene (Acox2), Cpt-1a). Probiotic strains from fermented products that are beneficial in terms of metabolic health are summarized in Table S1.

5.2. Fermented Cabbage and Sauerkraut

The term “sauerkraut” comes from German and means “sour cabbage”. Fermented cabbage probably originated in China, where cabbage was fermented with the addition of wine over 2000 years ago. In Europe, fermented cabbage was first produced 1000 years later, and in its production, wine was replaced by salt [135]. It is prepared from Brassica oleracea var. capitata [37,38], while in China, it is prepared from the Chinese cabbage (Brassica pekinesis) [136,137]. For sauerkraut preparation, cabbage is shredded into strips and compressed in jars or tanks with the addition of salt in the amount of 2–2.5%. Tight compression of cabbage is critical to obtaining the anaerobic conditions that promote LAB growth [38,135]. European sauerkraut is fermented in cabbage juice, which occurs after compressing cabbage, whereas Chinese sauerkraut is fermented in water [136]. The ready-to-eat product should be characterized by a sour taste and high hardness and crunchiness [38]. Pickled cabbage is also a traditional product of Turkey, where large pieces of cabbage are fermented in brine containing 6–8% salt [138].

5.2.1. Nutrients and Phytocompounds

Sauerkraut contains 4.28 g of carbohydrates, 0.14 g of fat, and 2.9 g of fiber. It is also a source of minerals, including sodium, potassium, and calcium, as well as vitamins K and C [135,138]. Historically, sauerkraut was an important source of vitamin C, which protected sailors from scurvy [135].
Fermented cabbage contains organic acids (lactic acid, malic acid), short-chain fatty acids (SCFAs), aldehydes (acetylaldehyde), esters (ethyl acetate, ethyl lactate), amino acids, alcohols, exopolysaccharides, biogenic amines, and other compounds [37,38,39]. Sauerkraut’s flavor is associated mainly with the presence of amino acids and organic acids [40]. In sauerkraut brine, free amino acids, including aromatic amino acids, significantly increase during fermentation [37]. Among SCFAs, acetic acid and butyric acid considerably increase during fermentation. The abundance of lactic acid, acetic acid, and some amino acids (Phe, Tyr) in brine is correlated with the presence of Lactiplantibacillus [37]. Spontaneous fermentation of sauerkraut was positively correlated with tartaric acid, malic acid, and lactic acid [40]. GABA was detected only in the early stage of fermentation. GABA content is positively correlated with the abundance of Pantoea, a bacterium that naturally colonizes Brassica leaves and metabolizes isothiocyanates during fermentation [37]. Glucosinolates in raw cabbage also undergo enzymatic degradation by the endogenous enzyme myrosinase. In fermented sauerkraut, only glucosinolate metabolites (including isothiocyanates and cyanides) have been identified. The predominant metabolite of glucobrassicin, one of the main glucosinolates in cabbage, is ascorbigen, a product of the reaction of indole-3-carbinol with vitamin C [41].
Methanol is the most abundant alcohol in sauerkraut. It is probably formed as a product of the enzymatic degradation of pectins contained in cabbage. It influences the sensory features of sauerkraut because it is a substrate that forms methyl esters. Among the terpenes, the most prevalent observed were geranyl acetone and β-damascenone [38]. Additionally, some biogenic amines, including tyramine and, in smaller amounts, putrescine, histamine, tryptamine, and cadaverine, were identified in sauerkraut (Table 1). The amount of biogenic amines is positively correlated with the presence of yeasts [38].

5.2.2. Microbiota

The fermentation process can be divided into three stages. The first phase (a ‘turbulent fermentation’) lasts 2–3 days [42]. The primary stage of fermentation is carried out by bacteria occurring in raw cabbage, including Pantoea, Serratia, Pseudomonas, Enterobacter, Pectobacterium, Lelliottia, Acinetobacter, and Buttiauxella [37]. During the first phase, the amount of oxygen and pH decrease, and extensive gas production occurs. Subsequently, a higher abundance of bacteria from the family Lactobacillaceae is observed, including species such as Lactiplantibacillus, Levilactobacillus, Secundilactobacillus, Pediococcus, Lentilactobacillus, Leuconostoc, and Paucilactobacillus [37]. The final phase (maturation) lasts up to several months and is crucial for determining the sensory attributes of the final product [135]. In the final product, L. plantarum is the predominant bacterium [37,39]. Aside from LAB, yeasts are also responsible for the unique taste, texture, and preservation of fermented cabbage. The yeasts found in sauerkraut include Pichia, Wickerhamomyces, Rhodotorula, Debaryomyces, and Clavispora [139]. Some yeast species, for instance, Debaryomyces hansenii and Cryptococcus macerans, may contribute to the shortening of shelf life and symptoms of spoilage [42]. There have also been attempts to use yeast as starter strains for sauerkraut fermentation [40,139]. The detailed characteristics of the microbial community of fermented cabbage are shown in Table 1.

5.2.3. The Relevance of Sauerkraut and Fermented Cabbage in the Context of MetS

Sauerkraut is a product with antioxidant [136,138] and anti-inflammatory properties [37]. Antioxidant properties can be attributed to the presence of antioxidant exopolysaccharides produced by Lactobacillus paracasei (currently Lacticaseibacillus paracasei), present in Indian pickled cabbage [140].
To the best of our knowledge, there are no in vivo studies on the effect of sauerkraut consumption on lipid and carbohydrate metabolism. However, there is research on the effects of particular L. plantarum strains isolated from fermented cabbage on components of the MetS. L. plantarum S4-1, isolated from Chinese sauerkraut, could be applied as a probiotic. L. plantarum S4-1 was able to assimilate cholesterol in vitro (in a medium), and milk fermented with this strain reduced serum cholesterol in mice [141]. L. plantarum S9, isolated from sauerkraut, is a probiotic strain with possible application in the prevention of MetS. Oral administration of L. plantarum S9 in MetS rodents resulted in an improvement in body weight, inflammation, insulin sensitivity, lipid profile, and accumulation of fat in the liver. The anti-inflammatory action was via the TLR4/NF-κB pathway. Probiotic supplementation was associated with a decreased expression of toll-like receptor 4 (TLR4), which is a receptor for bacterial lipopolysaccharide, inhibition of nuclear factor-κB (NF-κB) pathway activation, and decreased expression of inflammatory factors [142]. Furthermore, L. plantarum H31 may be considered a probiotic strain in the prevention and alleviation of diabetes. Exopolysaccharide from L. plantarum H31 inhibits α-amylase and promotes glucose uptake in hepatic cells via enhancement of the glucose transporter-4 gene (GLUT-4), protein kinase B gene (Akt-2), and AMPK expression [143].

6. Fermented Legumes

The chemical composition, microbiota, and health-promoting properties of fermented legumes are discussed below.

6.1. Fermented Soybean Products

Soybean (Glycine max (L.) Merr.) is a legume indigenous to Asian countries. Recently, soybeans have become one of the most popular oilseed plants and the cheapest source of plant-derived protein worldwide [144,145]. Raw seeds contain about 40% protein, 35% carbohydrates, 8–24% lipids, and dietary fiber [145]. A crucial group of biologically active compounds found in soybeans is isoflavones, followed by vitamins, saponins, flavonoids, and phenolic acids [144,146]. Soybean seeds contain 12 isoflavone isomers, such as aglycones (daidzein, genistein, and glycitein) and their corresponding β-glucosides, acetyl-glucosides, and malonylglucosides [44]. The biologically active compounds also include anti-nutritional compounds such as trypsin inhibitors and phytic acid [144,146]. Soybean is known as a functional food with cardioprotective properties. The meta-analysis conducted by Mohammadifard et al. [147] concluded that soy consumption has a statistically significant and favorable impact on lipid profile and glycemic parameters (fasting blood glucose (FBG), insulin level, and HOMA-IR) in patients with MetS [147].
In Asia, soybeans provide the basis for the production of various fermented products, for instance, natto, tempeh, kinema, douchi, cheonggukjang (CGJ), doenjang, miso, and fermented soy milk. The microbial communities responsible for soy fermentation can be bacteria (mainly Bacillus), mold (Rhizopus), or both [146]. Fermentation enhances the digestibility and nutritional value of soybeans, including an increase in the amount of free amino acids, vitamins, and GABA and the degradation of anti-nutritional compounds [45,146,148,149]. Furthermore, isoflavone glycosides, the predominant form of isoflavones in raw soybeans, are hydrolyzed in the presence of microbial β-glucosidases to more active aglycones with higher bioavailability [44,105].

6.1.1. Tempeh

Tempeh (or tempe) is a compact, cake-like product prepared from boiled soybeans by fermentation with Rhizopus. The product should have a firm texture, a nutty, mushroom-like flavor, and a white color, which is given by Rhizopus mycelium. Tempeh is a traditional soybean product that originated from Indonesia. It provides a good alternative to animal protein and is a staple protein source for Indonesians [150,151,152]. Production of tempeh includes steps such as soaking, dehulling, boiling, draining, and inoculating with spores of Rhizopus spp. The product is packed in leaves or perforated bags and incubated in semi-aerobic conditions. Tempeh can be prepared in different ways, including boiling, steaming, frying, or grilling. As a raw material for tempeh production, apart from soybeans, other legumes (chickpea, black gram, peas, and beans), grains (such as wheat, oats, and barley), or nuts may be used [150].

Nutrients and Phytocompounds

The unique nutritional value and chemical composition of tempeh are closely related to the enzymatic activity of the mold. Rhizopus produces enzymes, including proteases, lipases, and amylases, which are responsible for the degradation of complex compounds contained in soybeans [150,151]. Processing raw soybeans into tempeh results in some favorable nutritional changes, such as the degradation of starch and flatulence-causing oligosaccharides (raffinose and stachyose), and increasing protein quality and amounts of B2 and B3 vitamins [153,154,155]. Rhizopus also produces phytases that degrade phytic acid, resulting in the increased bioavailability of minerals such as iron, zinc, and magnesium, which are bound to phytate [148]. During fermentation, soy protein (albumin, globulin, and alkaline soluble proteins) degrades to amino acids and biologically active peptides. Amino acids, present in the largest amounts after 48 h of fermentation, are alanine, glutamic acid, and glycine. Fermentation also increases the number of essential amino acids, except for methionine. The amount of leucine is more than doubled, while the amount of phenylalanine increases more than four-fold [45,149]. Enhancement of lipase activity during fermentation results in an increase in FFA [156]. Additionally, during fermentation, the amount of GABA gradually increases (21.4 mg/100 g soybean/24 h) [45].
In raw soybean seeds, more than 99% of isoflavones occur, mainly as glucosides. Due to the high activity of β-glucosidase, produced by R. oligosporus during tempeh fermentation, the aglycone content increases over 20 times. The isoflavones contained in tempeh are daidzein, glycitein, and genistein, and their β-glucosides daidzin, glycitin, and genistin (Table 1). Daidzin and daidzein occur after 3 days of fermentation in high amounts (225.2 and 374.8 μmol/100 g), while glycitin and glycitein are present in smaller amounts (195.9 and 33.1 μmol/100 g) [44].

Microbiota

Currently, inoculation of soybeans by mold—Rhizopus spp.—is used in tempeh production. Traditionally, soybeans were wrapped into leaves, which led to accidental inoculation by the Rhizopus present on the leaf’s surface [150]. Among Rhizopus species, the most common is R. microsporus, while the amount of other species has declined due to the commercialization of tempeh production [46]. Among bacteria, the predominant phylum was found to be Firmicutes, and the predominant order was found to be Lactobacillales, including Lactobacillus agilis (currently Ligilactobacillus agilis), Lactobacillus fermentum (currently Limosilactobacillus fermentum), Lactobacillus mucosae (currently Limosilactobacillus mucosae), and Lactobacillus delbrucki [47]. The microbial community of tempeh also includes other bacteria (Clostridium), molds (Mucor and Rhizomucor), and Zygomycetes fungi (Absidia) (Table 1) [48,49]. Different modifications of the inoculum can be applied for special purposes. The addition of S. cerevisiae to the inoculum could improve tempeh’s health-promoting effect by enhancing β-glucan’s content and antibacterial activity against Escherichia coli [157], while Propionibacterium could be added to increase the amount of vitamin B12 [50].

The Relevance of Tempeh in the Context of MetS

Although tempeh is a valuable source of bioactive compounds and displays significant health-promoting properties, in Indonesia, it is still considered a “low-class” protein that is available to people who cannot afford meat [150]. In vivo and human studies confirmed anti-obesity [107,109], hypoglycemic [101,102,103], and hypolipidemic [100,102,106,108] effects of tempeh consumption (Table 2). Animal studies have demonstrated that the administration of tempeh can improve parameters connected with diabetes, including FBG, HbA1c, HOMA-IR, and oral glucose tolerance tests (OGTT) [98]. A decrease in HbA1c was also observed in diabetic patients after supplementation with freeze-dried tempeh [104]. In the diabetic rat model, tempeh administration improves the lipid profile by decreasing the concentration of total cholesterol (TC), LDL, and TG and increasing HDL levels [98]. The hypolipemic and hypoglycemic properties of tempeh seem to occur due to the probiotic properties of LAB, the high dietary fiber content, SCFAs, soy isoflavones, and soy protein [98,100,106,107,152]. Moreover, some bioactive peptides formed during fermentation can act as α-glucosidase, dipeptidyl peptidase 4 (DPP IV), and angiotensin-converting enzyme (ACE) inhibitors [149,158]. The chemical composition of tempeh, including free amino acids, peptides, and isoflavone aglycones, also provides antioxidant properties and decreases the amount of malondialdehyde, which is a product of lipid peroxidation [100,159,160]. Tempeh produced from germinated soybeans possesses stronger antioxidant activity and a higher protein content than tempeh produced from non-germinated soybeans. On the other hand, tempeh produced from non-germinated soybeans contains more isoflavones (116.02 vs. 80.13/ 100 g tempeh flour) and exhibits stronger α-amylase and α-glucosidase inhibition [161]. Furthermore, tempeh is a good source of resistant starch, including arabinoxylan (AX), which prevents TG liver accumulation, decreases FAS activity, blood glucose, and insulin levels, and improves the postprandial glycemic response. AX intake is also connected with an increase in the amount and activity of butyrate-producing gut Roseburia spp., which is decreased in diabetic subjects [152,162].

6.1.2. Natto

Natto is a fermented soybean product characterized by a sticky and slippery texture, nutty flavor, and sour aroma [163]. It is believed that natto originated either from the Yunnan province of China or from the Tohoku region of Japan, where it was invented by accident when boiled, spoiled soybeans were eaten and thought to be tasty. Over the years, natto gained popularity mainly in Japan. In the 1980s, natto appeared in supermarkets, and its consumption rose rapidly. Production includes steps such as soaking, steaming under pressure, inoculation, fermentation (40 °C, 16–18 h), and maturation. Natto is usually mixed with egg and condiments and served with rice for breakfast [163,164].

Nutrients and Phytocompounds

Natto contains 19 g of protein, 11 g of fat, and 5.4 g of dietary fiber per 100 g. It also provides large amounts of iron (8.6 mg/100 g), calcium (217 mg/100 g), and potassium (729 mg/100 g) [165]. The quantity of vitamin K2 considerably rises during fermentation, and its final content is 124 times higher than in unfermented soybean (880 mg/100 g) [163]. The fermentation process also affects the quality and quantity of amino acids. During fermentation, the amount of proline increases, contents of threonine, aspartic acid, serine, and valine are stable, while the amount of 11 other amino acids decreases dramatically [43]. Among the SCFAs, branched SCFAs (isobutyric and isovaleric acids) were detected, while their straight-chain isoforms (butyric and valeric) were absent [43]. Isoflavone aglycones are the major group of biologically active compounds in natto [43], followed by biogenic amines (spermine, spermidine, and tyramine) [166], exopolysaccharides (levan) [167], as well as volatile compounds, ketones, and pyrazines (Table 1) [43].

Microbiota

Before the isolation of a starter strain, rice straw, which is a natural habitat for B. subtilis spores, was used to initiate fermentation. Now, natto production uses a fermentation process with a starter culture of B. subtilis var. natto [168]. B. natto produces two crucial metabolites: γ-polyglutamic acid (γ-PGA) and nattokinase (NK) [169,170].
γ-PGA is a biopolymer consisting of glutamic monomers linked by peptide bonds between α-amino and γ-carboxylic groups [170]. It is responsible for the characteristic sticky consistency of natto [163]. Administration of γ-PGA in diabetic mice resulted in improved lipid metabolism, insulin resistance, HOMA-IR, reduced FBG, and enhanced expression of genes associated with the insulin pathway: INSR, Akt, IRS-1, and PI3K [171]. In the diet-induced obesity mouse model, γ-PGA supplementation reduced adipocyte size and improved the lipid profile (TG, LDL, and HDL levels), as well as parameters connected with glucose metabolism (HOMA-IR, insulin, and glucose levels). Supplementation was associated with a lower BW and food intake. γ-PGA influences AMPK, PPAR-γ, CPT-1, and SREBP-1 mRNA expression in the liver and adiponectin, leptin, GLUT-4, and PPAR-γ expression in white adipose tissue [172]. Moreover, γ-PGA consumption was associated with a reduction in visceral fat accumulation [173], while coadministration with levan (exopolysaccharide present in natto) also decreased epididymal fat, fat cell size, and leptin levels [169].
NK is an alkaline serine protease that exhibits robust antithrombotic and fibrinolytic activity [169]. NK is an ACE inhibitor [174,175]. Its supplementation reveals hypotensive effects both in Korean and in North American populations [176,177]. Supplementation with NK for 8 weeks decreased both systolic and diastolic BP [176,177] and reduced angiotensin (AGT) activity [177]. The hypotensive effect was more pronounced in the male population [176]. Following NK supplementation, a slight improvement in the lipid profile in patients with primary hypercholesterolemia was observed, but the effect was not statistically significant [178].

The Relevance of Natto in the Context of MetS

Natto could be considered as a food suitable for patients with MetS due to its antioxidative [110,112,114], anti-glycative [114], anti-obesity [112,113,179], anti-inflammatory [169,180], hypoglycemic [113,181,182,183,184,185], hypotensive [186], and hypolipidemic [111,112,113,114,180,185] properties (Table 2). It is worth noting that natto has a greater impact on glucose and lipid metabolism as well as on BP than unfermented soybeans [112,113,186].
Probably, γ-PGA, polysaccharides, and dipeptides are responsible for the hypoglycemic effect of natto [113,181,182,183,184] from γ-PGA-rich natto, which lowered the glucose incremental area under the curve and suppressed high postprandial glucose in the early stage after a meal. In addition, a meal consisting of rice and PGA-rich natto suppressed insulin secretion more than rice with low-PGA-content natto [182]. In addition, natto-derived polysaccharides also suppressed hyperglycemia and inhibited glucose uptake in vitro [183], while two peptides isolated from natto water extracts (Lys-Leu and Leu-Arg) were resistant to digestion and acted as DPP IV inhibitors [184].
The hypotensive effect of natto is probably due to ACE inhibitory properties, revealed by both NK [174,175] and dipeptides [186]. Seventy-two natto dipeptides have significant ACE inhibitory properties, and among them, the strongest enzyme inhibition was reported for Glu-Norval, Glu-Lys, and Thr-Arg [186].
Changes in lipid metabolism, including the inhibition of FA synthesis in the liver and FA catabolism, are responsible for natto’s anti-obesity effect. Natto suppresses FA synthesis in the liver by decreasing the expression of Fas, malic enzyme (Me), glucose-6-phosphate dehydrogenase X-linked (G6pdx) genes, and the transcription factor for these genes (Srebp-1c). Natto promotes FA catabolism in the liver by increasing the expression of the Cpt1 gene, which promotes FA β-oxidation, a consequence of a high-fat diet (HFD). Natto did not affect the transcription of other genes connected with β-oxidation (acyl-CoA oxidase gene (Aco), Cpt2, and Ppar-α) [112,113]. Moreover, the anti-obesity effect and improved lipid metabolism after natto consumption may occur as a consequence of increased expression of cholesterol 7 alpha-hydroxylase, decreased expression of sterol-regulatory element-binding protein and HMGCR, and suppressed activity of LXR target genes [179].
B. natto may be considered as a probiotic addressed to patients with metabolic disturbances. Supplementation with B. natto alleviates diet-induced obesity, visceral fat accumulation, and low-grade inflammation. Lower lipid accumulation and the hypolipidemic effect after B. natto supplementation are probably due to an increased expression of Ppar-α and decreased expression of Srebp-1c, while the anti-obesity effects are due to an increase in p-PI3K/PI3K, p-AKT/AKT, and IRS-1 protein expression. Although B. natto supplementation resulted in improvements in all parameters of the lipid profile, the most significant difference was reported for HDL, which increased by 60% after supplementation with B. natto at a dose of 1× 1010 CFU/mL (compared to the HFD group) [180,185].
Natto causes favorable changes in gut microbiota. Its consumption improves the Bacteroidetes/Firmicutes ratio, which is lower in subjects on HFD. Its consumption is associated with a decrease in Parabacteroidetes, connected with obesity and type 2 diabetes, and an increase in Allobaculum, which is associated with improvements in obesity-related parameters [112,113]. Moreover, B. natto supplementation promotes the growth of Verrucomicrobias. The main strain of Verrucomicrobias, A. muciniphila, is a probiotic strain adversely associated with obesity, low-grade inflammation, and diabetes [180].

6.1.3. Cheonggukjang

CGJ is a traditional Korean product manufactured from boiled soybeans. CGJ fermentation is induced by rice straw (a natural B. subtilis habitat) or by a commercially available starter culture (B. subtilis). The production includes steps such as soaking, cooking (121 °C, 0.5 h), cooling, inoculation, fermentation (40 °C, 48–72 h), and maturation. In contrast to fermented soybean products and traditional Korean fermented foods, CGJ does not contain salt. CGJ is often consumed as a gravy, served with boiled rice [51,187]. The main obstacle that limits CGJ consumption is its unpleasant smell while cooking. To improve its sensory qualities, there have been attempts to prepare CGJ with the addition of green tea, kiwi, radish, or red ginseng [188].

Nutrients and Phytocompounds

CGJ contains 20.9 g of protein and 18.4 g of fat per 100 g [52]. The most abundant amino acids are leucine and glutamic acid, followed by tyrosine, proline, and alanine [53]. As well as the above-mentioned products, CGJ is a significant source of physiologically active compounds, including dietary fiber, isoflavone aglycones, unsaturated FA, saponins, biogenic amines, GABA, γ-PGA, oligosaccharides, and enzymes (protease, cellulase, amylase) [51,52,189,190]. Characteristic compounds absent in the unfermented soybean include hydrocarbons (benzene, dichloromethane, 2,2,6-trimethyl decane), ketones (1,3-diphenyl-2-propanone, 2,3-butanedione, acetone), alcohols (2,3-butanediol), aldehydes, acids (lactic acid), esters, pyrazines, and aromatic compounds [53,54,191]. A compound that deserves attention for its beneficial health-promoting properties appears to be 1,3-diphenyl-2-propanone, which is a PPARα/γ dual agonist [54]. The detailed characteristics of the chemical composition of CGJ are shown in Table 1.
Similar to the previously described soybean fermented foods, CGJ contains biogenic amines (mostly tyramine, followed by β-phenylethylamine and putrescine [189]). The level of some biogenic amines in CGJ exceeds the safety level [189]. To reduce the content of biogenic amines, selected strains (e.g., B. licheniformis) [192] or some food additives (tartaric acid, sodium benzoate, potassium sorbate) could be applied [193].

Microbiota

The microbial community of naturally fermented Korean CGJ mainly consists of bacteria (95.83%), followed by viruses (2.26%), unclassified species (1.84%), eukaryotes, and archaea. The bacterial community of CGJ mainly consists of Bacillus (91.55%), followed by Brevibacillus, Acinetobacter, Carnobacterium, Paenibacillus, Cronobacter Enterococcus, Enterobacter, Terriglobus, Psychrobacter, and Virgibacillus (Table 1). In CGJ, 150 species of Bacillus have been identified. According to Tamang et al. [187], the most abundant Bacillus species is B. thermoamylovorans, while according to Jin et al. [193], the most prevalent species is B. piscis or B. licheniformis (depending on the method used). CGJ fermentation may be conducted with starter cultures, mainly Bacillus spp., but also Leuconostoc or Enterococcus [51].

The Relevance of CGJ in the Context of MetS

Consumption of tempeh or administration of CGJ as a fresh food or freeze-dried powder enhances the antioxidative status [96,194], mitigates inflammation [93,94], and improves the metabolic parameters (Table 2) [95]. CGJ exhibits an anti-diabetic effect [99], including an improvement in FBG levels [87,90,195], an insulin-sensitizing effect [196,197], and protection from β-cell apoptosis [92]. The molecular mechanism underlying the regulation of glucose metabolism and utilization is an enhanced expression of PPAR-γ and GLUT4 [195,196]. Water extracts from traditionally fermented CGJ (which contain mostly peptides) have stronger insulin-sensitizing properties (via increasing expression of PPAR-γ) than unfermented soybeans. The CGJ methanol extract (rich in isoflavone aglycones) protects β-cell viability and promotes insulin secretion in insulinoma cells more strongly than unfermented soybeans [197]. β-cell survival after CGJ consumption is also supported by stimulating the insulin/IGF-1 signaling cascade [195]. CGJ has an impact on blood glucose by suppressing the expression of PEPCK, a gene involved in gluconeogenesis, which is upregulated by HFD [92].
CGJ administration was associated with decreased body weight and improvement in levels of appetite-regulating hormones (both leptin and adiponectin) [87,88,92]. The anti-obesity effect of soybeans fermented by B. subtilis MORI, isolated from CGJ, was demonstrated by the suppression of preadipocyte differentiation, by decreased CCAAT element-binding protein α (CEBP/α) expression, and by increased ACC phosphorylation, although this action was reported only in vitro on 3T3-L1 preadipocytes [190,196]. Additionally, saponins contained in CGJ, mostly soyasapogenol B, enhance AMPK activation, which leads to FA synthase being switched off by phosphorylation and, consequently, inactivation of ACC [74,190]. The anti-obesity action is also associated with γ-PGA content and changes in isoflavones during fermentation. CGJ, in a traditional manner, reduced body weight and epididymal fat less effectively than a product fermented by a γ-PGA-producing strain [87].
The hypolipidemic effect of CGJ has been confirmed in both animal and human studies [87,89,90,91,94,96,198]. CGJ improved lipid metabolism by decreasing the expression of the transcription factors SREBP-1c and CEBP/α, both in hepatic and adipose tissue. Suppression of SREBP-1 inhibits hepatic lipogenesis and, in consequence, lipid accumulation, while lowering CEBP/α expression results in the reduced expression of adipogenic effector genes [94]. Moreover, CGJ supplementation could regulate lipid metabolism by increasing the liver expression of CPT-1 and ACO—genes connected to the regulation of FA β-oxidation [89]. Despite numerous studies confirming the beneficial effect of CGJ on metabolic parameters, Han et al. [97] reported no effect of CGJ consumption on inflammation, lipid profile, body weight, and glucose tolerance.

6.1.4. Kochujang

Kochujang is a Korean red pepper paste used as a sauce for meat, a dressing for vegetables, or a seasoning for soup and stew [115]. Traditional kochujang is made using fermented cooked soybeans (meju), red pepper powder, and glutinous rice. Fermentation is carried out in an open place and is conducted by bacteria and yeasts contained in the meju. The commercial ones are produced using koji, steamed rice with a starter culture (A. oryzae). The traditional product is ready to eat after six months of fermentation, while the commercial product is fermented only for 2 to 4 weeks [57,115,199]. Kochujang has a characteristic taste. It is sweet because of the hydrolysis of rice starch during fermentation, spicy due to the addition of red pepper, and savory due to the hydrolysis of soybean protein [115].

Nutrients and Phytzocompounds

Kochujang contains 8.3–19.3 g of protein, 1.1 g of lipids, 43.8 g of carbohydrates, and 14.6 g of fiber per 100 g [200]. Kochujang contains a substantial amount of salt (2.4 g/100 g) [201]. Similar to previously described fermented soybean products, kochujang contains isoflavones, though their content is more than 30 times lower than in CGJ [202]. Due to the addition of pepper, kochujang is a dietary source of capsaicin (Table 1). Capsaicin activates transient receptor potential vanilloid channel 1, which subsequently activates metabolic modulators, including PPAR-α, the glucagon-like peptide 1 gene (GLP-1), the uncoupling protein 1 gene (UCP1), and AMPK [203].

Microbiota

The method of preparation of kochujang in different regions has a significant impact on the types of microorganisms present in the product. Bacillus is the most abundant bacterial genus in kochujang [58,59]. Some Bacillus strains isolated from kochujang have anti-radical properties, SOD-like activity, and ACE inhibitory potential. The most effective ACE inhibitors were reported to be the B. amyloliquefaciens and B. velezensis strains [58]. B. amyloliquefaciens and one of the B. subtilis strains isolated from kochujang had bile salt tolerance, acid tolerance, colon cell adhesion ability, and a lack of B. cereus-related endotoxins expression. Hence, they could be considered as potential probiotic strains [58].
Although Park et al. [59] reported that LAB are not present in kochujang, Nam et al. [199] and Ha et al. [58] identified several LAB genera, including Lactobacillus, Tetragenococcus, and Weissella [199]. The dominant yeast species is Zygosaccharomyces pseudorouxii, and the most abundant fungus is Aspergillus oryzae (Table 1) [59].

The Relevance of Kochujang in the Context of MetS

Kochujang may be beneficial for patients with MetS due to its antioxidant [117], anti-obesity [57,115,117,118,204], hypolipemic [57,115,117,118], and anti-diabetic properties (Table 2) [115,116]. Some bioactive compounds, including p-coumaric acid, N6,N6,N6-trimethyllysine, and methionine, seem to be responsible for the anti-obesity effect [205]. In 3T3-L1 cells, inhibition of lipid accumulation, reduced adipocyte size, and leptin secretion after kochujang extract administration seem to be mediated by inhibition of PPAR-γ and SREBP-1c expression. Additionally, enhanced expression of hormone-sensitive lipase (HSL) stimulates lipolysis [204]. In an in vivo model, kochujang reduced body fat deposition by enhancing the expression of hepatic lipolysis enzymes (CPT-1 and ACS) and inhibiting lipolytic enzyme (ACC) expression. Anti-obesity action may also be supported by the upregulated expression of UCP-1, a gene associated with thermogenesis [115].
Kochujang acts as an α-glucosidase inhibitor in vitro [205]. In pancreatectomized rats, kochujang modulates glucose homeostasis by improving hepatic insulin sensitivity, not by promoting β-cell function. Moreover, kochujang reduced TG liver accumulation by enhancing STAT3-AMPK signaling, which reduced liver TG accumulation caused by the activation of AMPK [116]. The hypolipidemic effect may be due to the synergistic or additive effect of capsaicin and isoflavones in lipid metabolism [57].

6.1.5. Doenjang

Doenjang is a traditional Korean soybean salty and alkaline paste. In Korean cuisine, it is a basis for soups, stews, and salad dressings [19,55]. In the homemade process, doenjang is made by fermenting meju in water and salt, while the commercial product is made with koji (fermented rice), soybeans, and water, which shortens the fermentation period [206]. A characteristic feature of doenjang is its high salt content, which reaches up to 12% [55].

Nutrients and Phytocompounds

Traditionally, fermented doenjang is characterized by a higher amount of polyphenols than the soybean paste fermented with A. oryzae starter culture (omitting the traditional procedure): 382.08 vs. 226.85 mg/100 g [120]. This may be due to a lower Bacillus cell count and lower diversity in Bacillus species in the product fermented with the starter culture. Traditionally, fermented doenjang contains mainly isoflavone aglycones, in contrast to commercial doenjang, where isoflavones such as glycosides and maloylglycosides occur [206]. Similar to the soy product described above, doenjang contains free amino acids, biogenic amines (histamine and tyramine), pyrazines, FA, GABA, furfural, and a variety of volatile compounds [56,207]. Moreover, there is some evidence that selected B. subtilis, B. amyloliquefacience, and B. frigoritolerance strains isolated from doenjang produce a variety of volatile compounds, including peptides (di- and oligopeptides), volatile compounds (butanodienone, 3-methylbutanal, 3-hydroxy-2-butanone), and pyrazines, which affect the sensory characteristics of the product (Table 1) [208].

Microbiota

The two main bacterial orders in doenjang are Bacillales (85.93%), followed by Lactobacillales (13.58%) [55]. The bacterial community consists of genera such as Longilactobacillus, Tetragenococcus, Bacillus, and Leuconostoc [209]. According to Mun et al. [55], the predominant species is Bacillus paralicheniformis, which represents over 69% of the bacterial community in doenjang, while Lee et al. [206] reported that the main bacterial species in doenjang are Bacillus amyloliquefaciens, B. amyloliquefaciens subsp. plantarum, Bacillus licheniformis, and Bacillus subtilis. The dominant genus in the fungal community is Debaryomyces, followed by Wickerhamomyces and Mucor [209]. Animal treatment with a mixture of Bacillus originating from doenjang resulted in reduced body mass, reduced subcutaneous fat mass, and improved glucose tolerance [120]. The characteristics of the microbial community of doenjang are presented in Table 1.

The Relevance of Doenjang in the Context of MetS

It seems that doenjang may be beneficial in MetS. To date, it has been demonstrated that doenjang possesses antioxidant [206], anti-inflammatory [119], anti-obesity [60,119,120,121,122], hypotensive [55,121], anti-diabetic [120,121], and hypolipidemic properties (Table 2) [119,120,122].
In adipose tissue, doenjang affects the expression of some oxidative stress markers (heme-oxygenase-1 and p40phox) and inflammatory markers (tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1), and macrophage markers (CD68 and CD11c). This suggests that the biologically active compounds produced during fermentation and maturation are responsible for antioxidative and anti-inflammatory action [60]. The anti-obesity properties of doenjang are a result of its impact on leptin and adiponectin levels [60,120]. Doenjang could also promote hypotrophy and hypoplasia of adipocytes [121] and reduce the amount of crown-like structures, a pathological histological structure occurring in fatty tissue that consists of necrotic adipocytes surrounded by aggregated macrophages [60].
Although doenjang contains a high amount of salt, it seems to be beneficial in hypertension. In 3T3-L1 cells treated with salt and doenjang, a reduction in PPAR-γ, AGT, and Ace expression was observed compared to control cells. Doenjang was found to reduce PPAR-γ expression to a similar level as losartan (10−4 M) and to a greater level than captopril (10−4 M). Doenjang reduced Ace more effectively than losartan (10−4 M) and was comparable to captopril (10−4 M) [121]. A rodent model study conducted by Mun et al. [55] revealed that doenjang supplementation was associated with a reduction in serum renin levels. Additionally, the mRNA expression of Ace, angiotensin type 1 receptor, mineralocorticoid receptor, and Na+/Ca+ exchanger in the kidney cortex of doenjang-supplemented animals was significantly lower than in animals on a high-salt diet without additional supplementation [55].
In vitro and in vivo evidence indicates that doenjang acts as an α-glucosidase inhibitor [56,205] and affects insulin sensitivity through specific molecular mechanisms [120]. Long-fermented doenjang improved insulin sensitivity in skeletal muscle and liver. Additionally, doenjang suppresses the expression of genes related to inflammation in the liver (TNF-α, INFγ, MCP-1, IL-1β, and IL-6) and skeletal muscle (TNF-α, INFγ, and IL-1β). In skeletal muscle, doenjang enhanced AMPK phosphorylation [120]. Additionally, the reduction in plasma TNF-α and resistin levels may be linked with a hypolipidemic effect under HFD conditions [119]. Cha and colleagues [122] confirmed a lipid-lowering effect in humans. They suggested that this effect can be attributed to the action of isoflavones.

6.2. Other Examples of Fermented Legumes

Although the most popular fermented legume is soybean, other fermented legumes are also of interest. The fermentation of beans, fava beans, or lentils may be beneficial in terms of creating new functional foods. Since literature reports on various fermented legumes are limited, these products will be characterized briefly, excluding the precise characteristics of the microorganisms and bioactive compounds.
Similar to soybeans, the breakdown of proteins into bioactive peptides occurs during the fermentation of other legume seeds. Both the peptides present in L. plantarum 299v fermented fava bean, as well as the peptides present in B. subtilis fermented lentils, reveal antioxidant and ACE inhibitory properties in vitro [210,211].
In addition, fermented mung beans could be considered a functional food in preventing MetS. In diabetic mice, a fermented mung bean extract improved glucose levels and the lipid profile [212], while in hypercholesterolemic rodents, mung bean extract reduced serum TC, TG, and LDL and improved the level of HDL. Moreover, the extract enhanced the expression of apolipoprotein-E (ApoE) and downregulated the expression of neuropeptide Y (Npy), which was found to be associated with an increased appetite and lower energy expenditure in obese rodents [213]. The hypolipemic effect was also shown by fermented red beans. An extract prepared from B. subtilis fermented red bean improved the serum lipid levels, as well as liver TC content and PPAR-α protein [214].

7. Microbial Metabolites

The health-promoting properties of fermented products may be attributed to the formation of novel compounds that were not present in raw ingredients before fermentation. Research suggests that fermented products may have a stronger effect on the parameters related to metabolism than raw ingredients [86,197,213]. The beneficial effects on MetS components are attributed to metabolites that include free amino acids (methionine, ornithine), peptides (di- and oligopeptides), exopolysaccharides, polyphenols (tyrosol, HT), bacterial enzymes (NK), and isoflavone aglycones, characteristic for fermented soybean products. The bioactive compounds in fermented plant foods are summarized in Figure 2.

8. New Trends in Fermented Foods

During the fermentation process, various modifications can be applied to obtain products with more favorable sensory characteristics or health-promoting properties. Using starter strains can provide great opportunities to obtain products with improved quality and desirable properties. Fermented plant products can be fermented with probiotic starter strains and, in consequence, used as a carrier for the probiotic bacteria. Previously, the products used for this purpose were dairy-based and unavailable to people with lactose or milk protein intolerance [215].
Due to the high salt content of most fermented products, a noteworthy research trend is the development of products with a reduced salt content. To maintain favorable sensory characteristics with a reduced salt content, the addition of a starter culture may be beneficial. An example of a product that could be considered in this category is low-sodium olives produced using a Lactobacillus plantarum F3. 3 starter strain [23,215]. In some cases, strains can produce some beneficial constituents or degrade undesirable compounds. For example, Levilactobacillus brevis, Lactiplantibacillus plantarum, or Enterococcus faecium strains could be applied to increase the GABA content in kimchi [124], or selected Lactiplantibacillus plantarum strains can be applied in olive production due to their oleuropeinolytic activity [216].
An alternative way to obtain products with health benefits may be an addition of herbs [124], plant extracts [217], and condiments that are not normally used in a certain product [218]. An example of an alternative product is kimchi with a variety of ingredients, including mushrooms, pear, Chinese pepper, sea tangle juice, green tea, mistletoe extract, and probiotic strains [16,131], or table olives made with a polyphenol-rich olive leaf extract [217].

9. Conclusions and Future Perspectives

Fermented plant-based foods can enrich the diet with probiotics and biologically active compounds, both those contained in plants and those originating from microbial metabolism. This review provides insights into the potential use of fermented fruits, vegetables, and legumes as a functional food and source of probiotic strains and biologically active compounds, which can be applied in the prevention and alleviation of metabolic disturbances. Fermented plant-based foods are a dietary source of bioactive peptides, free amino acids, short-chain fatty acids, GABA, and exopolysaccharides. Fermented soybean products, due to the high content of isoflavone aglycones, may be a superfood used in improving lipid profiles. Natto, which contains γ-PGA, is a well-studied product that may offer multiple benefits when included in the diet of individuals with MetS. γ-PGA contributes to the regulation of metabolism by modulating the expression of PPAR-γ, INSR, and Akt. In the context of metabolic disorders, olives represent another potentially beneficial dietary component. Hydroxytyrosol, produced from oleuropein as a result of lactic acid fermentation, has been shown to support blood pressure regulation and influence the expression of key metabolic regulators, including AMPK, PPAR-α, and PPAR-γ.
Some products, such as kimchi and fermented soybeans, mostly characteristic of Asian countries, have been extensively studied in terms of their impact on metabolic health (in both animal and human models). Despite the presence of certain bacterial strains and bioactive compounds in European fermented foods (table olives or sauerkraut), which are proven to be beneficial to metabolic health, there are no studies on the impact of these foods in general on metabolic parameters.
Globalization has led to the growing popularity of certain fermented products that were previously available only in the regions where they were traditionally produced. Fermented products made from soy or cabbage are considered relatively easy to produce in various parts of the world, due to the low cost of raw materials and processing, as well as the availability of specific starter cultures. Fermented foods are gaining popularity among younger consumers. The consumption of fermented products among younger individuals is driven not only by curiosity toward novel foods but also by increasing public awareness of their potential health benefits. Examples of products originating from other regions that have been well accepted by consumers include kimchi and fermented soy products (such as tempeh), which are now available on European markets. It is noteworthy that the scientific literature rarely discusses potential adverse effects or contraindications associated with the consumption of fermented plant-based foods. The most commonly cited contraindication to consuming fermented products is hypertension. This contraindication is not clear-cut, as some studies have reported the ‘salt paradox’—a phenomenon in which fermented products exert a hypotensive effect despite containing high levels of salt.
The primary challenges in the production of plant-derived fermented foods are to obtain products with consistent, reproducible quality, low in anti-nutritional compounds, and high in health-promoting constituents and probiotic microorganisms. It is also crucial to consider the sensory characteristics of fermented products and to formulate recommendations regarding appropriate portions of the products. Furthermore, studies on the development of dietary supplements, based on freeze-dried fermented foods and extracts, could expand their application.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu17121989/s1, Table S1: Effect of bacterial strains isolated from fermented vegetables and legumes on parameters related to metabolic syndrome.

Author Contributions

Conceptualization, T.S., A.Z.K. and K.B.; writing—original draft preparation, K.B.; writing—review and editing, A.Z.K. and T.S.; visualization, K.B.; supervision, A.Z.K. and T.S. All authors have read and agreed to the published version of the manuscript.

Funding

The article is part of a PhD dissertation titled ‘Plant-based extracts in the prevention and treatment of metabolic disorders’, prepared during the Doctoral School at the Wrocław University of Environmental and Life Sciences. The APC is financed by the Wrocław University of Environmental and Life Sciences.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
MetSMetabolic syndrome
CVDCardiovascular disease
LABLactic acid bacteria
GRASGenerally Recognized as Safe
HTHydroxytyrosol
AMPKAMP-activated protein kinase
ApoBApolipoprotein B
ACCAcetyl-CoA carboxylase
DGATDiacylglycerol acyltransferase
HMGCR3-Hydroxy-3-methyl-glutaryl-CoA reductase
FFAFree fatty acids
HDMPPA3-(40-Hydroxyl-30,50-dimethoxyphenyl) propionic acid
TGTriglycerides
BPBlood pressure
BMIBody Mass Index
HOMA-IRHomeostatic Model Assessment for Insulin Resistance
QUICKIQuantitative Insulin Sensitivity Check Index
TLR 4Toll-like receptor 4
NF-κBNuclear factor-κB
CGJCheonggukjang
DJDoenjang
OGTTOral Glucose Tolerance Tests
DPP IVDipeptidyl peptidase 4
ACEAngiotensin-converting enzyme
AXArabinoxylan
γ-PGAγ-polyglutamic acid
NKNattokinase
HFDHigh-fat diet
CEBP/αCCAAT element binding protein α
HSLHormone-sensitive lipase
KJKochujang
TNF-αTumor necrosis factor α
MCP-1Monocyte chemoattractant protein-1
AGTAngiotensinogen
LXRαLiver X receptor alpha gene
SREBP-1cSterol regulatory element-binding protein 1c gene
SREBP-2Sterol regulatory element-binding protein 2 gene
FASFatty acid synthase gene
LdlrLow density lipoprotein receptor gene
Agpat51-Acyl-sn-glycerol-3-phosphate acyltransferase 5 gene
Acox2Acyl-CoA oxidase gene
AktProtein kinase B
GLP-1Glucagon-like peptide 1 gene
UCP1Uncoupling protein 1 gene
MeMalic enzyme
G6pdxGlucose-6-phosphate dehydrogenase X-linked
AcoAcyl-CoA oxidase gene
PEPCKPhosphoenolpyruvate carboxykinase 1

References

  1. Fahed, G.; Aoun, L.; Bou Zerdan, M.; Allam, S.; Bou Zerdan, M.; Bouferraa, Y.; Assi, H.I. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 2022, 23, 786. [Google Scholar] [CrossRef]
  2. Castro-Barquero, S.; Ruiz-León, A.M.; Sierra-Pérez, M.; Estruch, R.; Casas, R. Dietary Strategies for Metabolic Syndrome: A Comprehensive Review. Nutrients 2020, 12, 2983. [Google Scholar] [CrossRef]
  3. Singh, R.; Zogg, H.; Wei, L.; Bartlett, A.; Ghoshal, U.C.; Rajender, S.; Ro, S. Gut Microbial Dysbiosis in the Pathogenesis of Gastrointestinal Dysmotility and Metabolic Disorders. J. Neurogastroenterol. Motil. 2021, 27, 19–34. [Google Scholar] [CrossRef]
  4. Dobrowolski, P.; Prejbisz, A.; Kuryłowicz, A.; Baska, A.; Burchardt, P.; Chlebus, K.; Dzida, G.; Jankowski, P.; Jaroszewicz, J.; Jaworski, P.; et al. Metabolic Syndrome—A New Definition and Management Guidelines. Arter. Hypertens. 2022, 26, 99–121. [Google Scholar] [CrossRef]
  5. Samtiya, M.; Aluko, R.E.; Dhewa, T.; Moreno-Rojas, J.M. Potential Health Benefits of Plant Food-Derived Bioactive Components: An Overview. Foods 2021, 10, 839. [Google Scholar] [CrossRef]
  6. Şanlier, N.; Gökcen, B.B.; Sezgin, A.C. Health Benefits of Fermented Foods. Crit. Rev. Food Sci. Nutr. 2019, 59, 506–527. [Google Scholar] [CrossRef]
  7. Song, E.; Ang, L.; Lee, H.W.; Kim, M.-S.; Kim, Y.J.; Jang, D.; Lee, M.S. Effects of Kimchi on Human Health: A Scoping Review of Randomized Controlled Trials. J. Ethn. Foods 2023, 10, 7. [Google Scholar] [CrossRef]
  8. Tamang, J.P.; Cotter, P.D.; Endo, A.; Han, N.S.; Kort, R.; Liu, S.Q.; Mayo, B.; Westerik, N.; Hutkins, R. Fermented Foods in a Global Age: East Meets West. Compr. Rev. Food Sci. Food Saf. 2020, 19, 184–217. [Google Scholar] [CrossRef]
  9. Zhao, Y.-S.; Eweys, A.S.; Zhang, J.-Y.; Zhu, Y.; Bai, J.; Darwesh, O.M.; Zhang, H.-B.; Xiao, X. Fermentation Affects the Antioxidant Activity of Plant-Based Food Material through the Release and Production of Bioactive Components. Antioxidants 2021, 10, 2004. [Google Scholar] [CrossRef] [PubMed]
  10. Sayın, F.K.; Alkan, S.B. The Effect Of Pickling On Total Phenolic Contents And Antioxidant Activity Of 10 Vegetables. Food Health 2015, 1, 135–141. [Google Scholar] [CrossRef]
  11. Verni, M.; Verardo, V.; Rizzello, C.G. How Fermentation Affects the Antioxidant Properties of Cereals and Legumes. Foods 2019, 8, 362. [Google Scholar] [CrossRef]
  12. Gänzle, M.G. Food Fermentations for Improved Digestibility of Plant Foods—An Essential Ex Situ Digestion Step in Agricultural Societies? Curr. Opin. Food Sci. 2020, 32, 124–132. [Google Scholar] [CrossRef]
  13. Starzyńska-Janiszewska, A.; Stodolak, B.; Mickowska, B. Effect of Controlled Lactic Acid Fermentation on Selected Bioactive and Nutritional Parameters of Tempeh Obtained from Unhulled Common Bean (Phaseolus vulgaris) Seeds. J. Sci. Food Agric. 2014, 94, 359–366. [Google Scholar] [CrossRef]
  14. Vinderola, G.; Sanders, M.E.; Salminen, S. The Concept of Postbiotics. Foods 2022, 11, 1077. [Google Scholar] [CrossRef] [PubMed]
  15. Ghnimi, S.; Guizani, N. Vegetable Fermentation and Pickling. In Handbook of Vegetables and Vegetable Processing, 2nd ed.; Sinha, N.K., Ed.; John Wiley & Sons: Ames, IA, USA, 2018; Volume 1, pp. 407–427. ISBN 9781119098935. [Google Scholar]
  16. Kim, H.-Y.; Park, K.-Y. Clinical Trials of Kimchi Intakes on the Regulation of Metabolic Parameters and Colon Health in Healthy Korean Young Adults. J. Funct. Foods 2018, 47, 325–333. [Google Scholar] [CrossRef]
  17. Song, H.S.; Whon, T.W.; Kim, J.; Lee, S.H.; Kim, J.Y.; Kim, Y.B.; Choi, H.-J.; Rhee, J.-K.; Roh, S.W. Microbial Niches in Raw Ingredients Determine Microbial Community Assembly during Kimchi Fermentation. Food Chem. 2020, 318, 126481. [Google Scholar] [CrossRef]
  18. Hatti-Kaul, R.; Chen, L.; Dishisha, T.; Enshasy, H.E. Lactic Acid Bacteria: From Starter Cultures to Producers of Chemicals. FEMS Microbiol. Lett. 2018, 365, fny213. [Google Scholar] [CrossRef]
  19. Tamang, J.P.; Watanabe, K.; Holzapfel, W.H. Review: Diversity of Microorganisms in Global Fermented Foods and Beverages. Front. Microbiol. 2016, 7, 377. [Google Scholar] [CrossRef]
  20. Shrestha, A.K.; Dahal, N.R.; Ndungutse, V. Bacillus Fermentation of Soybean: A Review. J. Food Sci. Technol. Nepal 2010, 6, 1–9. [Google Scholar] [CrossRef]
  21. Tamang, J.P. Biochemical And Modern Identification Techniques|Microfloras of Fermented Foods. In Encyclopedia of Food Microbiology, 2nd ed.; Batt, C.A., Tortorello, M.L., Eds.; Academic Press: Cambridge, MA, USA; Elsevier: Amsterdam, The Netherlands, 2014; Volume 1, pp. 249–252. ISBN 9780123847331. [Google Scholar]
  22. Anal, A.K. Quality Ingredients and Safety Concerns for Traditional Fermented Foods and Beverages from Asia: A Review. Fermentation 2019, 5, 8. [Google Scholar] [CrossRef]
  23. Perpetuini, G.; Prete, R.; Garcia-Gonzalez, N.; Khairul Alam, M.; Corsetti, A. Table Olives More than a Fermented Food. Foods 2020, 9, 178. [Google Scholar] [CrossRef] [PubMed]
  24. Rocha, J.; Borges, N.; Pinho, O. Table Olives and Health: A Review. J. Nutr. Sci. 2020, 9, e57. [Google Scholar] [CrossRef] [PubMed]
  25. Johnson, R.L.; Mitchell, A.E. Reducing Phenolics Related to Bitterness in Table Olives. J. Food Qual. 2018, 2018, 3193185. [Google Scholar] [CrossRef]
  26. Lanza, B.; Ninfali, P. Antioxidants in Extra Virgin Olive Oil and Table Olives: Connections between Agriculture and Processing for Health Choices. Antioxidants 2020, 9, 41. [Google Scholar] [CrossRef] [PubMed]
  27. Portilha-Cunha, M.F.; Macedo, A.C.; Malcata, F.X. A Review on Adventitious Lactic Acid Bacteria from Table Olives. Foods 2020, 9, 948. [Google Scholar] [CrossRef]
  28. Argyri, K.; Doulgeraki, A.I.; Manthou, E.; Grounta, A.; Argyri, A.A.; Nychas, G.-J.E.; Tassou, C.C. Microbial Diversity of Fermented Greek Table Olives of Halkidiki and Konservolia Varieties from Different Regions as Revealed by Metagenomic Analysis. Microorganisms 2020, 8, 1241. [Google Scholar] [CrossRef]
  29. De Castro, A.; Sánchez, A.H.; López-López, A.; Cortés-Delgado, A.; Medina, E.; Montaño, A. Microbiota and Metabolite Profiling of Spoiled Spanish-Style Green Table Olives. Metabolites 2018, 8, 73. [Google Scholar] [CrossRef]
  30. Simões, L.; Fernandes, N.; Teixeira, J.; Abrunhosa, L.; Dias, D.R. Brazilian Table Olives: A Source of Lactic Acid Bacteria with Antimycotoxigenic and Antifungal Activity. Toxins 2023, 15, 71. [Google Scholar] [CrossRef]
  31. Aksay, O.; Selli, S.; Kelebek, H. LC-DAD-ESI-MS/MS-Based Assessment of the Bioactive Compounds in Fresh and Fermented Caper (Capparis spinosa) Buds and Berries. Food Chem. 2021, 337, 127959. [Google Scholar] [CrossRef]
  32. Sun, Y.; Yang, T.; Wang, C. Capparis spinosa L. as a Potential Source of Nutrition and Its Health Benefits in Foods: A Comprehensive Review of Its Phytochemistry, Bioactivities, Safety, and Application. Food Chem. 2023, 409, 135258. [Google Scholar] [CrossRef]
  33. Francesca, N.; Barbera, M.; Martorana, A.; Saiano, F.; Gaglio, R.; Aponte, M.; Moschetti, G.; Settanni, L. Optimised Method for the Analysis of Phenolic Compounds from Caper (Capparis spinosa L.) Berries and Monitoring of Their Changes during Fermentation. Food Chem. 2016, 196, 1172–1179. [Google Scholar] [CrossRef] [PubMed]
  34. Chang, H.-W.; Kim, K.-H.; Nam, Y.-D.; Roh, S.W.; Kim, M.-S.; Jeon, C.O.; Oh, H.-M.; Bae, J.-W. Analysis of Yeast and Archaeal Population Dynamics in Kimchi Using Denaturing Gradient Gel Electrophoresis. Int. J. Food Microbiol. 2008, 126, 159–166. [Google Scholar] [CrossRef] [PubMed]
  35. Lee, S.H.; Whon, T.W.; Roh, S.W.; Jeon, C.O. Unraveling Microbial Fermentation Features in Kimchi: From Classical to Meta-Omics Approaches. Appl. Microbiol. Biotechnol. 2020, 104, 7731–7744. [Google Scholar] [CrossRef] [PubMed]
  36. Choi, I.H.; Noh, J.S.; Han, J.-S.; Kim, H.J.; Han, E.-S.; Song, Y.O. Kimchi, a Fermented Vegetable, Improves Serum Lipid Profiles in Healthy Young Adults: Randomized Clinical Trial. J. Med. Food 2013, 16, 223–229. [Google Scholar] [CrossRef]
  37. Gaudioso, G.; Weil, T.; Marzorati, G.; Solovyev, P.; Bontempo, L.; Franciosi, E.; Bertoldi, L.; Pedrolli, C.; Tuohy, K.M.; Fava, F. Microbial and Metabolic Characterization of Organic Artisanal Sauerkraut Fermentation and Study of Gut Health-Promoting Properties of Sauerkraut Brine. Front. Microbiol. 2022, 13, 929738. [Google Scholar] [CrossRef]
  38. Satora, P.; Skotniczny, M.; Strnad, S.; Piechowicz, W. Chemical Composition and Sensory Quality of Sauerkraut Produced from Different Cabbage Varieties. LWT 2021, 136, 110325. [Google Scholar] [CrossRef]
  39. Georgieva, A.; Petkova, M.; Todorova, E.; Gotcheva, V.; Angelov, A. Isolation and Selection of Sauerkraut Lactic Acid Bacteria Producing Exopolysaccharides. BIO Web Conf. 2023, 58, 02001. [Google Scholar] [CrossRef]
  40. Liu, Y.; Chen, X.; Li, F.; Shi, H.; He, M.; Ge, J.; Ling, H.; Cheng, K. Analysis of Microbial Diversity and Metabolites in Sauerkraut Products with and without Microorganism Addition. Foods 2023, 12, 1164. [Google Scholar] [CrossRef]
  41. Ciska, E.; Honke, J.; Drabińska, N. Changes in Glucosinolates and Their Breakdown Products during the Fermentation of Cabbage and Prolonged Storage of Sauerkraut: Focus on Sauerkraut Juice. Food Chem. 2021, 365, 130498. [Google Scholar] [CrossRef]
  42. Satora, P.; Celej, D.; Skotniczny, M.; Trojan, N. Identifying Yeast Occurring in Commercial and Farm-Made Sauerkraut. Żywność Nauka. Technologia. Jakość 2017, 113, 27–36. [Google Scholar] [CrossRef]
  43. Chen, X.; Lu, Y.; Zhao, A.; Wu, Y.; Zhang, Y.; Yang, X. Quantitative Analyses for Several Nutrients and Volatile Components during Fermentation of Soybean by Bacillus subtilis Natto. Food Chem. 2022, 374, 131725. [Google Scholar] [CrossRef]
  44. Liu, W.-T.; Huang, C.-L.; Liu, R.; Yang, T.-C.; Lee, C.-L.; Tsao, R.; Yang, W.-J. Changes in Isoflavone Profile, Antioxidant Activity, and Phenolic Contents in Taiwanese and Canadian Soybeans during Tempeh Processing. LWT 2023, 186, 115207. [Google Scholar] [CrossRef]
  45. Handoyo, T.; Morita, N. Structural and Functional Properties of Fermented Soybean (Tempeh) by Using Rhizopus oligosporus. Int. J. Food Prop. 2006, 9, 347–355. [Google Scholar] [CrossRef]
  46. Hartanti, A.T.; Rahayu, G.; Hidayat, I. Rhizopus Species from Fresh Tempeh Collected from Several Regions in Indonesia. HAYATI J. Biosci. 2015, 22, 136–142. [Google Scholar] [CrossRef]
  47. Radita, R.; Suwanto, A.; Kurosawa, N.; Wahyudi, A.; Rusmana, I. Firmicutes Is the Predominant Bacteria in Tempeh. Int. Food Res. J. 2018, 25, 2313–2320. [Google Scholar]
  48. Lim, S.L.; Tay, S.T. Diversity and Killer Activity of Yeasts in Malaysian Fermented Food Samples. Trop. Biomed. 2011, 28, 438–443. [Google Scholar]
  49. Wikandari, R.; Millati, R.; Lennartsson, P.R.; Harmayani, E.; Taherzadeh, M.J. Isolation and Characterization of Zygomycetes Fungi from Tempe for Ethanol Production and Biomass Applications. Appl. Biochem. Biotechnol. 2012, 167, 1501–1512. [Google Scholar] [CrossRef]
  50. He, M.T.; Howell, K.S. Vitamin-B12 Enrichment in Tempeh by Co-Culture with Propionibacterium freudenreichii during Fermentation. bioRxiv 2022. [Google Scholar] [CrossRef]
  51. Kim, I.-S.; Hwang, C.-W.; Yang, W.-S.; Kim, C.-H. Current Perspectives on the Physiological Activities of Fermented Soybean-Derived Cheonggukjang. Int. J. Mol. Sci. 2021, 22, 5746. [Google Scholar] [CrossRef]
  52. Piao, Y.-Z.; Eun, J.-B. Physicochemical Characteristics and Isoflavones Content during Manufacture of Short-Time Fermented Soybean Product (Cheonggukjang). J. Food Sci. Technol. 2020, 57, 2190–2197. [Google Scholar] [CrossRef]
  53. Park, M.K.; Cho, I.H.; Lee, S.; Choi, H.-K.; Kwon, D.-Y.; Kim, Y.-S. Metabolite Profiling of Cheonggukjang, a Fermented Soybean Paste, during Fermentation by Gas Chromatography-Mass Spectrometry and Principal Component Analysis. Food Chem. 2010, 122, 1313–1319. [Google Scholar] [CrossRef]
  54. Arulkumar, R.; Jung, H.-J.; Noh, S.-G.; Park, D.; Chung, H.-Y. Cheonggukjang-Specific Component 1,3-Diphenyl-2-Propanone as a Novel PPARα/γ Dual Agonist: An In Vitro and In Silico Study. Int. J. Mol. Sci. 2021, 22, 10884. [Google Scholar] [CrossRef]
  55. Mun, E.-G.; Park, J.E.; Cha, Y.-S. Effects of Doenjang, a Traditional Korean Soybean Paste, with High-Salt Diet on Blood Pressure in Sprague–Dawley Rats. Nutrients 2019, 11, 2745. [Google Scholar] [CrossRef]
  56. Lee, H.Y.; Haque, M.A.; Cho, D.Y.; Jeong, J.B.; Lee, J.H.; Lee, G.Y.; Jang, M.Y.; Lee, J.H.; Cho, K.M. Comparison of Microbial Diversity and Metabolites on Household and Commercial Doenjang. Food Chem. X 2024, 21, 101101. [Google Scholar] [CrossRef] [PubMed]
  57. Lim, J.-H.; Jung, E.-S.; Choi, E.-K.; Jeong, D.-Y.; Jo, S.-W.; Jin, J.-H.; Lee, J.-M.; Park, B.-H.; Chae, S.-W. Supplementation with Aspergillus oryzae-Fermented Kochujang Lowers Serum Cholesterol in Subjects with Hyperlipidemia. Clin. Nutr. 2015, 34, 383–387. [Google Scholar] [CrossRef] [PubMed]
  58. Ha, G.; Yang, H.-J.; Ryu, M.-S.; Jeong, S.-J.; Jeong, D.-Y.; Park, S. Bacterial Community and Anti-Cerebrovascular Disease-Related Bacillus Species Isolated from Traditionally Made Kochujang from Different Provinces of Korea. Microorganisms 2021, 9, 2238. [Google Scholar] [CrossRef]
  59. Park, S.-J.; Chang, J.-H.; Cha, S.-K.; Moon, G.-S. Analysis of the Bacterial Composition During Kochujang, a Korean Traditional Fermented Hot Pepper-Soybean Paste, Fermentation. Food Sci. Biotechnol. 2009, 18, 1035–1037. [Google Scholar]
  60. Nam, Y.R.; Won, S.B.; Chung, Y.-S.; Kwak, C.S.; Kwon, Y.H. Inhibitory Effects of Doenjang, Korean Traditional Fermented Soybean Paste, on Oxidative Stress and Inflammation in Adipose Tissue of Mice Fed a High-Fat Diet. Nutr. Res. Pract. 2015, 9, 235–241. [Google Scholar] [CrossRef]
  61. Boskou, D.; Camposeo, S.; Clodoveo, M.L. Table Olives as Sources of Bioactive Compounds. In Olive and Olive Oil Bioactive Constituents; Boskou, D., Ed.; AOCS Press: Urbana, IL, USA, 2015; pp. 217–259. ISBN 978-1630670412. [Google Scholar]
  62. Salis, C.; Papadakis, I.E.; Hagidimitriou, M. Identification and Quantification of Phenolic Compounds in Fresh and Processed Table Olives of Cv. ‘Kalamata’. Not. Bot. Horti. Agrobo. 2021, 49, 12394. [Google Scholar] [CrossRef]
  63. Marsilio, V.; Seghetti, L.; Iannucci, E.; Russi, F.; Lanza, B.; Felicioni, M. Use of a Lactic Acid Bacteria Starter Culture during Green Olive (Olea europaea L Cv Ascolana Tenera) Processing. J. Sci. Food Agric. 2005, 85, 1084–1090. [Google Scholar] [CrossRef]
  64. Cocolin, L.; Alessandria, V.; Botta, C.; Gorra, R.; Filippis, F.D.; Ercolini, D.; Rantsiou, K. NaOH-Debittering Induces Changes in Bacterial Ecology during Table Olives Fermentation. PLoS ONE 2013, 8, e69074. [Google Scholar] [CrossRef] [PubMed]
  65. Anagnostopoulos, D.A.; Bozoudi, D.; Tsaltas, D. Enterococci Isolated from Cypriot Green Table Olives as a New Source of Technological and Probiotic Properties. Fermentation 2018, 4, 48. [Google Scholar] [CrossRef]
  66. Martorana, A.; Alfonzo, A.; Gaglio, R.; Settanni, L.; Corona, O.; La Croce, F.; Vagnoli, P.; Caruso, T.; Moschetti, G.; Francesca, N. Evaluation of Different Conditions to Enhance the Performances of Lactobacillus pentosus OM13 during Industrial Production of Spanish-Style Table Olives. Food Microbiol. 2017, 61, 150–158. [Google Scholar] [CrossRef]
  67. Pistarino, E.; Aliakbarian, B.; Casazza, A.A.; Paini, M.; Cosulich, M.E.; Perego, P. Combined Effect of Starter Culture and Temperature on Phenolic Compounds during Fermentation of Taggiasca Black Olives. Food Chem. 2013, 138, 2043–2049. [Google Scholar] [CrossRef]
  68. de Pablos, R.M.; Espinosa-Oliva, A.M.; Hornedo-Ortega, R.; Cano, M.; Arguelles, S. Hydroxytyrosol Protects from Aging Process via AMPK and Autophagy; a Review of Its Effects on Cancer, Metabolic Syndrome, Osteoporosis, Immune-Mediated and Neurodegenerative Diseases. Pharmacol. Res. 2019, 143, 58–72. [Google Scholar] [CrossRef]
  69. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on the Substantiation of Health Claims Related to Polyphenols in Olive and Protection of LDL Particles from Oxidative Damage (ID 1333, 1638, 1639, 1696, 2865), Maintenance of Normal Blood HDL Cholesterol Concentrations (ID 1639), Maintenance of Normal Blood Pressure (ID 3781), “Anti-Inflammatory Properties” (ID 1882), “Contributes to the Upper Respiratory Tract Health” (ID 3468), “Can Help to Maintain a Normal Function of Gastrointestinal Tract” (3779), and “Contributes to Body Defences against External Agents” (ID 3467) Pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2011, 9, 2033. [Google Scholar] [CrossRef]
  70. Pastor, R.; Bouzas, C.; Tur, J.A. Beneficial Effects of Dietary Supplementation with Olive Oil, Oleic Acid, or Hydroxytyrosol in Metabolic Syndrome: Systematic Review and Meta-Analysis. Free Radic. Biol. Med. 2021, 172, 372–385. [Google Scholar] [CrossRef]
  71. Amorati, R.; Valgimigli, L.; Panzella, L.; Napolitano, A.; d’Ischia, M. 5-S-Lipoylhydroxytyrosol, a Multidefense Antioxidant Featuring a Solvent-Tunable Peroxyl Radical-Scavenging 3-Thio-1,2-Dihydroxybenzene Motif. J. Org. Chem. 2013, 78, 9857–9864. [Google Scholar] [CrossRef] [PubMed]
  72. Diallinas, G.; Rafailidou, N.; Kalpaktsi, I.; Komianou, A.C.; Tsouvali, V.; Zantza, I.; Mikros, E.; Skaltsounis, A.L.; Kostakis, I.K. Hydroxytyrosol (HT) Analogs Act as Potent Antifungals by Direct Disruption of the Fungal Cell Membrane. Front. Microbiol. 2018, 9, 2624. [Google Scholar] [CrossRef]
  73. Officioso, A.; Panzella, L.; Tortora, F.; Alfieri, M.L.; Napolitano, A.; Manna, C. Comparative Analysis of the Effects of Olive Oil Hydroxytyrosol and Its 5-S-Lipoyl Conjugate in Protecting Human Erythrocytes from Mercury Toxicity. Oxid. Med. Cell. Longev. 2018, 2018, 9042192. [Google Scholar] [CrossRef]
  74. Priore, P.; Siculella, L.; Gnoni, G.V. Extra Virgin Olive Oil Phenols Down-Regulate Lipid Synthesis in Primary-Cultured Rat-Hepatocytes. J. Nutr. Biochem. 2014, 25, 683–691. [Google Scholar] [CrossRef] [PubMed]
  75. Hao, J.; Shen, W.; Yu, G.; Jia, H.; Li, X.; Feng, Z.; Wang, Y.; Weber, P.; Wertz, K.; Sharman, E.; et al. Hydroxytyrosol Promotes Mitochondrial Biogenesis and Mitochondrial Function in 3T3-L1 Adipocytes. J. Nutr. Biochem. 2010, 21, 634–644. [Google Scholar] [CrossRef] [PubMed]
  76. Jiménez-López, J.; Ruiz-Medina, A.; Ortega-Barrales, P.; Llorent-Martínez, E.J. Phytochemical Profile and Antioxidant Activity of Caper Berries (Capparis spinosa L.): Evaluation of the Influence of the Fermentation Process. Food Chem. 2018, 250, 54–59. [Google Scholar] [CrossRef] [PubMed]
  77. Khavasi, N.; hosein Somi, M.; Khadem, E.; Faramarzi, E.; Ayati, M.H.; Fazljou, S.M.B.; Torbati, M. Effect of Daily Caper Fruit Pickle Consumption on Disease Regression in Patients with Non-Alcoholic Fatty Liver Disease: A Double-Blinded Randomized Clinical Trial. Adv. Pharm. Bull. 2017, 7, 645–650. [Google Scholar] [CrossRef]
  78. Perna, S.; Rafique, A.; Rondanelli, M.; Allehdan, S.; Riso, P.; Marino, M. Effect of Caper Fruit (Capparis spinosa L.) Consumption on Liver Enzymes, Lipid Profile, Fasting Plasma Glucose, and Weight Loss. A Systematic Review and a Preliminary Meta-Analysis of Randomized Controlled Trials. Biomed. Pharmacother. 2023, 168, 115638. [Google Scholar] [CrossRef]
  79. Özcan, M.M.; Uslu, N. The Effect of Fermentation with Different Additives on Bioactive Compounds, Antioxidant Activity, Phenolic Component, Fatty Acid Composition and Mineral Substance Contents of Capers Fruits. Food Meas. 2023, 17, 3896–3908. [Google Scholar] [CrossRef]
  80. Pérez Pulido, R.; Ben Omar, N.; Abriouel, H.; Lucas López, R.; Martínez Cañamero, M.; Gálvez, A. Microbiological Study of Lactic Acid Fermentation of Caper Berries by Molecular and Culture-Dependent Methods. Appl. Environ. Microbiol. 2005, 71, 7872–7879. [Google Scholar] [CrossRef]
  81. Özcan, M.M. Pickling and Storage of Caperberries (Capparis Spp.). Z. Lebensm. Unters. Forsch. 1999, 208, 379–382. [Google Scholar] [CrossRef]
  82. Khavasi, N.; Somi, M.; Khadem, E.; Ayati, M.H.; Torbati, M.; Fazljou, S. Daily Consumption of the Capparis Spinosa Reduces Some Atherogenic Indices in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized, Double-Blind, Clinical Trial. Iran Red Crescent Med. J. 2018, 20, e63446. [Google Scholar] [CrossRef]
  83. Sardari, S.; Fallahi, F.; Emadi, F.; Davati, A.; Khavasi, N.; Gholamifesharaki, M.; Esmaeili, S.S. Daily Consumption of Caper Fruit Along With Atorvastatin Has Synergistic Effects in Hyperlipidemic Patients: Randomized Clinical Trial. Galen Med. J. 2019, 8, e1345. [Google Scholar] [CrossRef]
  84. Kim, E.K.; An, S.-Y.; Lee, M.-S.; Kim, T.H.; Lee, H.-K.; Hwang, W.S.; Choe, S.J.; Kim, T.-Y.; Han, S.J.; Kim, H.J.; et al. Fermented Kimchi Reduces Body Weight and Improves Metabolic Parameters in Overweight and Obese Patients. Nutr. Res. 2011, 31, 436–443. [Google Scholar] [CrossRef]
  85. Park, J.-A.; Tirupathi Pichiah, P.B.; Yu, J.-J.; Oh, S.-H.; Daily, J.W.; Cha, Y.-S. Anti-Obesity Effect of Kimchi Fermented with Weissella koreensis OK1-6 as Starter in High-Fat Diet-Induced Obese C57BL/6J Mice. J. Appl. Microbiol. 2012, 113, 1507–1516. [Google Scholar] [CrossRef]
  86. An, S.-Y.; Lee, M.S.; Jeon, J.Y.; Ha, E.S.; Kim, T.H.; Yoon, J.Y.; Ok, C.-O.; Lee, H.-K.; Hwang, W.-S.; Choe, S.J.; et al. Beneficial Effects of Fresh and Fermented Kimchi in Prediabetic Individuals. Ann. Nutr. Metab. 2013, 63, 111–119. [Google Scholar] [CrossRef] [PubMed]
  87. Choi, J.-H.; Pichiah, P.B.T.; Kim, M.-J.; Cha, Y.-S. Cheonggukjang, a Soybean Paste Fermented with B. licheniformis-67 Prevents Weight Gain and Improves Glycemic Control in High Fat Diet Induced Obese Mice. J. Clin. Biochem. Nutr. 2016, 59, 31–38. [Google Scholar] [CrossRef]
  88. Kim, D.-J.; Jeong, Y.-J.; Kwon, J.-H.; Moon, K.-D.; Kim, H.-J.; Jeon, S.-M.; Lee, M.-K.; Park, Y.B.; Choi, M.-S. Beneficial Effect of Chungkukjang on Regulating Blood Glucose and Pancreatic β-Cell Functions in C75BL/KsJ- Db/Db Mice. J. Med. Food 2008, 11, 215–223. [Google Scholar] [CrossRef]
  89. Soh, J.-R.; Shin, D.-H.; Kwon, D.Y.; Cha, Y.-S. Effect of Cheonggukjang Supplementation upon Hepatic Acyl-CoA Synthase, Carnitine Palmitoyltransferase I, Acyl-CoA Oxidase and Uncoupling Protein 2 mRNA Levels in C57BL/6J Mice Fed with High Fat Diet. Genes Nutr. 2008, 2, 365–369. [Google Scholar] [CrossRef] [PubMed]
  90. Kim, J.; Choi, J.N.; Choi, J.H.; Cha, Y.S.; Muthaiya, M.J.; Lee, C.H. Effect of Fermented Soybean Product (Cheonggukjang) Intake on Metabolic Parameters in Mice Fed a High-fat Diet. Mol. Nutr. Food. Res. 2013, 57, 1886–1891. [Google Scholar] [CrossRef]
  91. Park, E.-S.; Choi, S.-K.; Zhang, X.-H.; Choi, U.-K.; Seo, J.-S. Effect of Cheonggukjang Made with Germinated Soybean on Lipid Contents and Fecal Excretion of Neutral Steroids in Rats Fed a High Cholesterol Diet. Food Sci. Biotechnol. 2013, 22, 15–21. [Google Scholar] [CrossRef]
  92. Yang, H.J.; Kim, H.J.; Kim, M.J.; Kang, S.; Kim, D.S.; Daily, J.W.; Jeong, D.Y.; Kwon, D.Y.; Park, S. Standardized Chungkookjang, Short-Term Fermented Soybeans with Bacillus lichemiformis, Improves Glucose Homeostasis as Much as Traditionally Made Chungkookjang in Diabetic Rats. J. Clin. Biochem. Nutr. 2013, 52, 49–57. [Google Scholar] [CrossRef]
  93. Byun, M.-S.; Yu, O.-K.; Cha, Y.-S.; Park, T.-S. Korean Traditional Chungkookjang Improves Body Composition, Lipid Profiles and Atherogenic Indices in Overweight/Obese Subjects: A Double-Blind, Randomized, Crossover, Placebo-Controlled Clinical Trial. Eur. J. Clin. Nutr. 2016, 70, 1116–1122. [Google Scholar] [CrossRef]
  94. Kim, J. Anti-Obesity and Anti-Inflammation Effects of Cheonggukjang in C57Bl/6 Mice with High Fat Diet Induced Obesity. J. Life Sci. 2017, 27, 1357–1368. [Google Scholar] [CrossRef]
  95. Back, H.-I.; Kim, S.-R.; Yang, J.-A.; Kim, M.-G.; Chae, S.-W.; Cha, Y.-S. Effects of Chungkookjang Supplementation on Obesity and Atherosclerotic Indices in Overweight/Obese Subjects: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J. Med. Food 2011, 14, 532–537. [Google Scholar] [CrossRef]
  96. Shin, S.-K.; Kwon, J.-H.; Jeong, Y.-J.; Jeon, S.-M.; Choi, J.-Y.; Choi, M.-S. Supplementation of Cheonggukjang and Red Ginseng Cheonggukjang Can Improve Plasma Lipid Profile and Fasting Blood Glucose Concentration in Subjects with Impaired Fasting Glucose. J. Med. Food 2011, 14, 108–113. [Google Scholar] [CrossRef]
  97. Han, A.L.; Jeong, S.-J.; Ryu, M.-S.; Yang, H.-J.; Jeong, D.-Y.; Seo, Y.-B. Evaluation of Body Changes and the Anti-Obesity Effect after Consumption of Korean Fermented Food, Cheonggukjang: Randomized, Double-Blind Clinical Trial. Foods 2023, 12, 2190. [Google Scholar] [CrossRef]
  98. Huang, Y.-C.; Wu, B.-H.; Chu, Y.-L.; Chang, W.-C.; Wu, M.-C. Effects of Tempeh Fermentation with Lactobacillus plantarum and Rhizopus oligosporus on Streptozotocin-Induced Type II Diabetes Mellitus in Rats. Nutrients 2018, 10, 1143. [Google Scholar] [CrossRef]
  99. Masdar, H.; Satriyasumatri, T.; Hakiki, M.R.; Rafisyahputra, M.; Juananda, D. Histological Apperarance of Diabetes-Rat Pancreas Administrated by Soybean Compared to Tempeh. AIP Conf. Proc. 2019, 2108, 020012. [Google Scholar] [CrossRef]
  100. Dewi, L.; Lestari, L.A.; Astiningrum, A.N.; Fadhila, V.; Amala, N.; Bakrie, M.A.; Hidayah, N. Tempeh and Red Ginger Flour for Hypercholesterolemic Rats. Nutr. Food Sci. 2021, 51, 41–49. [Google Scholar] [CrossRef]
  101. Kusuma, R.; Widada, J.; Huriyati, E.; Julia, M. Naturally Acquired Lactic Acid Bacteria from Fermented Cassava Improves Nutrient and Anti-Dysbiosis Activity of Soy Tempeh. Open Access Maced. J. Med. Sci. 2021, 9, 1148–1155. [Google Scholar] [CrossRef]
  102. Prasetyastuti, P.; Ghozali, D.S. The Effects of Soyferment-Tempeh on Lipid Profile, Retinol-Binding Protein 4 (RBP4), and Phosphoenolpyruvate Carboxykinase (PEPCK) Gene Expression in Type 2 Diabetic Mice. Indones. J. Pharm. 2021, 32, 193–200. [Google Scholar] [CrossRef]
  103. Wicaksono, H.; Prasetyastuti, P.; Hastuti, P.; Sadewa, A.H. The Effect of Fermented Tempeh Aerobic Anaerobic (FETAA) on Pancreatic Duodenal Homeobox 1 (Pdx1) Gene Expression and HOMA-Beta Index in Diabetic Mice. Acta Biochim. 2021, 4, 11. [Google Scholar] [CrossRef]
  104. Su, H.; Chen, W.; Lu, J.; Chao, H.; Liang, Y.; Haruka, S.; Hsu, W.; Wu, M.; Tsai, M. The Effects of Using Tempeh as a Supplement for Type 2 Diabetes. Food Sci. Nutr. 2023, 11, 3339–3347. [Google Scholar] [CrossRef] [PubMed]
  105. Zahra, F.A.; Fulyani, F.; Maharani, N.; Anjani, G.; Noer, E.R. Effects of Fermented Tempeh Using Rhizopus oligosporus and Lactobacillus rhamnosus GG on Body Weight, Lee Index, High Sensitivity C Reactive Protein and Lipid Profile of Obese Rats. J. Biomed. Transl. Res. 2023, 9, 31–38. [Google Scholar] [CrossRef]
  106. Afifah, D.N.; Nabilah, N.; Supraba, G.T.; Pratiwi, S.N.; Nuryanto; Sulchan, M. The Effects of Tempeh Gembus, an Indonesian Fermented Food, on Lipid Profiles in Women with Hyperlipidemia. Curr. Nutr. Food Sci. 2020, 16, 56–64. [Google Scholar] [CrossRef]
  107. Isnawati, M.; Larasati, M.D.; Muninggar, D.L.P.; Afifah, D.N.; Suromo, L.B.; Sulchan, M. The Effect of Processed Tempeh Gembus Administration on Blood Glucose in Obese Women. IOP Conf. Ser. Earth Environ. Sci. 2020, 519, 012034. [Google Scholar] [CrossRef]
  108. Su, H.-K.; Tsai, M.-H.; Chao, H.-R.; Wu, M.-L.; Lu, J.-H. Data on Effect of Tempeh Fermentation on Patients with Type II Diabetes. Data Brief 2021, 38, 107310. [Google Scholar] [CrossRef]
  109. Zulaikha, H.N.; Dijaya Muliadi, R.; Kartawidjajaputra, F.; Antono, L. Cholesterol-Lowering Effect of Soy Nuts and Tempeh on Hypercholesterolemic Subjects. J. Funct. Food Nutraceutical 2023, 4, 95–102. [Google Scholar] [CrossRef]
  110. Iwai, K.; Nakaya, N.; Kawasaki, Y.; Matsue, H. Antioxidative Functions of Natto, A Kind of Fermented Soybeans:  Effect on LDL Oxidation and Lipid Metabolism in Cholesterol-Fed Rats. J. Agric. Food Chem. 2002, 50, 3597–3601. [Google Scholar] [CrossRef]
  111. Park, K.-J.; Kang, J.-I.; Kim, T.-S.; Yeo, I.-H. The Antithrombotic and Fibrinolytic Effect of Natto in Hypercholesterolemia Rats. Prev. Nutr. Food Sci. 2012, 17, 78–82. [Google Scholar] [CrossRef]
  112. Kushida, M.; Okouchi, R.; Iwagaki, Y.; Asano, M.; Du, M.X.; Yamamoto, K.; Tsuduki, T. Fermented Soybean Suppresses Visceral Fat Accumulation in Mice. Mol. Nutr. Food Res. 2018, 62, 1701054. [Google Scholar] [CrossRef]
  113. Tamura, M.; Watanabe, J.; Noguchi, T.; Nishikawa, T. High Poly-γ-Glutamic Acid-Containing Natto Improves Lipid Metabolism and Alters Intestinal Microbiota in Mice Fed a High-Fat Diet. J. Clin. Biochem. Nutr. 2024, 74, 47–56. [Google Scholar] [CrossRef]
  114. Taniguchi-Fukatsu, A.; Yamanaka-Okumura, H.; Naniwa-Kuroki, Y.; Nishida, Y.; Yamamoto, H.; Taketani, Y.; Takeda, E. Natto and Viscous Vegetables in a Japanese-Style Breakfast Improved Insulin Sensitivity, Lipid Metabolism and Oxidative Stress in Overweight Subjects with Impaired Glucose Tolerance. Br. J. Nutr. 2012, 107, 1184–1191. [Google Scholar] [CrossRef] [PubMed]
  115. Koo, B.; Seong, S.-H.; Dae, Y.K.; Hee, S.S.; Cha, Y.-S. Fermented Kochujang Supplement Shows Anti-Obesity Effects by Controlling Lipid Metabolism in C57BL/6J Mice Fed High Fat Diet. Food Sci. Biotechnol. 2008, 17, 336–342. [Google Scholar]
  116. Kwon, D.Y.; Hong, S.M.; Ahn, I.S.; Kim, Y.S.; Shin, D.W.; Park, S. Kochujang, a Korean Fermented Red Pepper plus Soybean Paste, Improves Glucose Homeostasis in 90% Pancreatectomized Diabetic Rats. Nutrition 2009, 25, 790–799. [Google Scholar] [CrossRef]
  117. Lee, Y.; Cha, Y.-S.; Park, Y.; Lee, M. PPARγ2 C1431T Polymorphism Interacts with the Antiobesogenic Effects of Kochujang, a Korean Fermented, Soybean-Based Red Pepper Paste, in Overweight/Obese Subjects: A 12-Week, Double-Blind Randomized Clinical Trial. J. Med. Food 2017, 20, 610–617. [Google Scholar] [CrossRef]
  118. Han, A.L.; Jeong, S.-J.; Ryu, M.-S.; Yang, H.-J.; Jeong, D.-Y.; Park, D.-S.; Lee, H.K. Anti-Obesity Effects of Traditional and Commercial Kochujang in Overweight and Obese Adults: A Randomized Controlled Trial. Nutrients 2022, 14, 2783. [Google Scholar] [CrossRef] [PubMed]
  119. Park, N.Y.; Rico, C.W.; Lee, S.C.; Kang, M.Y. Comparative Effects of Doenjang Prepared from Soybean and Brown Rice on the Body Weight and Lipid Metabolism in High Fat-Fed Mice. J. Clin. Biochem. Nutr. 2012, 51, 235–240. [Google Scholar] [CrossRef]
  120. Kim, M.-S.; Kim, B.; Park, H.; Ji, Y.; Holzapfel, W.; Kim, D.-Y.; Hyun, C.-K. Long-Term Fermented Soybean Paste Improves Metabolic Parameters Associated with Non-Alcoholic Fatty Liver Disease and Insulin Resistance in High-Fat Diet-Induced Obese Mice. Biochem. Biophys. Res. Commun. 2018, 495, 1744–1751. [Google Scholar] [CrossRef]
  121. Woo, H.; Han, A.; Park, J.E.; Cha, Y.-S. Korean Fermented Soybean Paste (Doenjang) Has Anti-Obesity and Anti-Hypertensive Effects via the Renin-Angiotensin System (RAS) in High-Fat Diet-Induced Obese Rats. PLoS ONE 2023, 18, e0291762. [Google Scholar] [CrossRef]
  122. Cha, Y.-S.; Yang, J.-A.; Back, H.-I.; Kim, S.-R.; Kim, M.-G.; Jung, S.-J.; Song, W.O.; Chae, S.-W. Visceral Fat and Body Weight Are Reduced in Overweight Adults by the Supplementation of Doenjang, a Fermented Soybean Paste. Nutr. Res. Pract. 2012, 6, 520–526. [Google Scholar] [CrossRef]
  123. Surya, R.; Lee, A.G.-Y. Exploring the Philosophical Values of Kimchi and Kimjang Culture. J. Ethn. Foods 2022, 9, 20. [Google Scholar] [CrossRef]
  124. Lee, S.-J.; Jeon, H.-S.; Yoo, J.-Y.; Kim, J.-H. Some Important Metabolites Produced by Lactic Acid Bacteria Originated from Kimchi. Foods 2021, 10, 2148. [Google Scholar] [CrossRef]
  125. Jung, S.J.; Kim, M.J.; Chae, S.W. Quality and Functional Characteristics of Kimchi Made with Organically Cultivated Young Chinese Cabbage (Olgari-Baechu). J. Ethn. Foods 2016, 3, 150–158. [Google Scholar] [CrossRef]
  126. Kim, H.J.; Kwon, M.S.; Hwang, H.; Choi, H.-S.; Lee, W.-J.; Choi, S.-P.; Jo, H.; Hong, S.W. A Review of the Health Benefits of Kimchi Functional Compounds and Metabolites. Microbiol. Biotechnol. Lett. 2023, 51, 353–373. [Google Scholar] [CrossRef]
  127. Kim, R.M.; Lee, K.-J.; Young Kim, H.; Hee Kim, J.; Kim, Y.-B.; Sok, D.-E. Effect of Various Kimchi Extracts on the Hepatic Glutathione S-Transferase Activity of Mice. Int. Food Res. 1998, 31, 389–394. [Google Scholar] [CrossRef]
  128. Choi, Y.-J.; Yong, S.; Lee, M.J.; Park, S.J.; Yun, Y.-R.; Park, S.-H.; Lee, M.-A. Changes in Volatile and Non-Volatile Compounds of Model Kimchi through Fermentation by Lactic Acid Bacteria. LWT 2019, 105, 118–126. [Google Scholar] [CrossRef]
  129. Lee, M.-A.; Choi, Y.-J.; Lee, H.; Hwang, S.; Lee, H.J.; Park, S.J.; Chung, Y.B.; Yun, Y.-R.; Park, S.-H.; Min, S.; et al. Influence of Salinity on the Microbial Community Composition and Metabolite Profile in Kimchi. Fermentation 2021, 7, 308. [Google Scholar] [CrossRef]
  130. Park, J.E.; Oh, S.-H.; Cha, Y.-S. Lactobacillus brevis OPK-3 from Kimchi Prevents Obesity and Modulates the Expression of Adipogenic and Pro-Inflammatory Genes in Adipose Tissue of Diet-Induced Obese Mice. Nutrients 2020, 12, 604. [Google Scholar] [CrossRef] [PubMed]
  131. Lee, K.-H.; Song, J.-L.; Park, E.-S.; Ju, J.; Kim, H.-Y.; Park, K.-Y. Anti-Obesity Effects of Starter Fermented Kimchi on 3T3-L1 Adipocytes. Prev. Nutr. Food Sci. 2015, 20, 298–302. [Google Scholar] [CrossRef]
  132. Lim, S.; Moon, J.H.; Shin, C.M.; Jeong, D.; Kim, B. Effect of Lactobacillus Sakei, a Probiotic Derived from Kimchi, on Body Fat in Koreans with Obesity: A Randomized Controlled Study. Endocrinol. Metab. 2020, 35, 425–434. [Google Scholar] [CrossRef]
  133. Oh, M.-R.; Jang, H.-Y.; Lee, S.-Y.; Jung, S.-J.; Chae, S.-W.; Lee, S.-O.; Park, B.-H. Lactobacillus plantarum HAC01 Supplementation Improves Glycemic Control in Prediabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients 2021, 13, 2337. [Google Scholar] [CrossRef]
  134. Seo, S.H.; Hong, J.; Son, I.H.; Han, Y.H.; Hyun, T. Association of Korean fermented cabbage kimchi consumption with an incidence of metabolic syndrome: 10-year follow-up results of the Korean Genome and Epidemiology Study. J. Nutr. Health 2019, 52, 569. [Google Scholar] [CrossRef]
  135. Peñas, E.; Martinez-Villaluenga, C.; Frias, J. Sauerkraut: Production, Composition, and Health Benefits. In Fermented Foods in Health and Disease Prevention; Frias, J., Martinez-Villaluenga, C., Peñas, E., Eds.; Academic Press: Cambridge, MA, USA; Elsevier: Amsterdam, The Netherlands, 2017; pp. 557–576. ISBN 9780128023099. [Google Scholar]
  136. Zhou, H.; Wang, S.; Liu, W.; Chang, L.; Zhu, X.; Mu, G.; Qian, F. Probiotic Properties of Lactobacillus Paraplantarum LS-5 and Its Effect on Antioxidant Activity of Fermented Sauerkraut. Food Biosci. 2023, 52, 102489. [Google Scholar] [CrossRef]
  137. Zhou, Q.; Zang, S.; Zhao, Z.; Li, X. Dynamic Changes of Bacterial Communities and Nitrite Character during Northeastern Chinese Sauerkraut Fermentation. Food Sci. Biotechnol. 2017, 27, 79–85. [Google Scholar] [CrossRef]
  138. Erdoğan, A.K.; Filiz, B.E. Menaquinone Content and Antioxidant Properties of Fermented Cabbage Products: Effect of Different Fermentation Techniques and Microbial Cultures. J. Funct. Foods 2023, 102, 105467. [Google Scholar] [CrossRef]
  139. Satora, P.; Strnad, S. Impact of Selected Yeast Strains on Quality Parameters of Obtained Sauerkraut. Appl. Sci. 2024, 14, 3462. [Google Scholar] [CrossRef]
  140. Shankar, T.; Palpperumal, S.; Kathiresan, D.; Sankaralingam, S.; Balachandran, C.; Baskar, K.; Hashem, A.; Alqarawi, A.A.; Abd_Allah, E.F. Biomedical and Therapeutic Potential of Exopolysaccharides by Lactobacillus paracasei Isolated from Sauerkraut: Screening and Characterization. Saudi J. Biol. Sci. 2021, 28, 2943–2950. [Google Scholar] [CrossRef]
  141. Yu, Z.; Zhang, X.; Li, S.; Li, C.; Li, D.; Yang, Z. Evaluation of Probiotic Properties of Lactobacillus Plantarum Strains Isolated from Chinese Sauerkraut. World J. Microbiol. Biotechnol. 2013, 29, 489–498. [Google Scholar] [CrossRef]
  142. Zhao, L.; Shen, Y.; Wang, Y.; Wang, L.; Zhang, L.; Zhao, Z.; Li, S. Lactobacillus plantarum S9 Alleviates Lipid Profile, Insulin Resistance, and Inflammation in High-Fat Diet-Induced Metabolic Syndrome Rats. Sci. Rep. 2022, 12, 15490. [Google Scholar] [CrossRef] [PubMed]
  143. Huang, Z.; Lin, F.; Zhu, X.; Zhang, C.; Jiang, M.; Lu, Z. An Exopolysaccharide from Lactobacillus plantarum H31 in Pickled Cabbage Inhibits Pancreas α-Amylase and Regulating Metabolic Markers in HepG2 Cells by AMPK/PI3K/Akt Pathway. Int. J. Biol. Macromol. 2020, 143, 775–784. [Google Scholar] [CrossRef]
  144. Chatterjee, C.; Gleddie, S.; Xiao, C.-W. Soybean Bioactive Peptides and Their Functional Properties. Nutrients 2018, 10, 1211. [Google Scholar] [CrossRef]
  145. Medic, J.; Atkinson, C.; Hurburgh, C.R. Current Knowledge in Soybean Composition. J. Americ. Oil Chem. Soc. 2014, 91, 363–384. [Google Scholar] [CrossRef]
  146. Hashimoto, Y.; Hamaguchi, M.; Fukui, M. Fermented Soybean Foods and Diabetes. J. Diabetes Investig. 2023, 14, 1329–1340. [Google Scholar] [CrossRef] [PubMed]
  147. Mohammadifard, N.; Sajjadi, F.; Haghighatdoost, F. Effects of Soy Consumption on Metabolic Parameters in Patients with Metabolic Syndrome: A Systematic Review and Meta-Analysis. EXCLI J. 2021, 20, 665–685. [Google Scholar] [CrossRef] [PubMed]
  148. Feng, X.M.; Passoth, V.; Eklund-Jonsson, C.; Alminger, M.L.; Schnürer, J. Rhizopus oligosporus and Yeast Co-Cultivation during Barley Tempeh Fermentation—Nutritional Impact and Real-Time PCR Quantification of Fungal Growth Dynamics. Food Microbiol. 2007, 24, 393–402. [Google Scholar] [CrossRef]
  149. Sitanggang, A.B.; Lesmana, M.; Budijanto, S. Membrane-Based Preparative Methods and Bioactivities Mapping of Tempe-Based Peptides. Food Chem. 2020, 329, 127193. [Google Scholar] [CrossRef]
  150. Ahnan-Winarno, A.D.; Cordeiro, L.; Winarno, F.G.; Gibbons, J.; Xiao, H. Tempeh: A Semicentennial Review on Its Health Benefits, Fermentation, Safety, Processing, Sustainability, and Affordability. Comp. Rev. Food Sci. Food Safe 2021, 20, 1717–1767. [Google Scholar] [CrossRef]
  151. Mani, V.; Ming, L.C. Tempeh and Other Fermented Soybean Products Rich in Isoflavones. In Fermented Foods in Health and Disease Prevention; Frias, J., Martinez-Villaluenga, C., Peñas, E., Eds.; Academic Press: Cambridge, MA, USA; Elsevier: Amsterdam, The Netherlands, 2017; pp. 453–474. ISBN 9780128023099. [Google Scholar]
  152. Setiawan, S.I.; Sudirman, A.R.; Aditia, D.A.; Yonathan, K.; Dwijayanti, A. Potency of Indonesian Soybean Tempeh in Enhancement of Gut Roseburia Spp. and Bifidobacterium Spp. to Prevent Type II Diabetes Mellitus and Hyperlipidemia: Fried or Steamed? In Proceedings of the 8th Conference of Indonesian Students Association in South Korea, Daejeon, Republic of Korea, 5–6 September 2015. [Google Scholar] [CrossRef]
  153. Liem, I.T.; Steinkraus, K.H.; Cronk, T.C. Production of Vitamin B-12 in Tempeh, a Fermented Soybean Food. Appl. Environ. Microbiol. 1977, 34, 773–776. [Google Scholar] [CrossRef]
  154. Syida, W.K.; Noriham, A.; Normah, I.; Yusuf, M. Changes in Chemical Composition and Amino Acid Content of Soy Protein Isolate (SPI) from Tempeh. Int. Food Res. J. 2018, 25, 1528–1533. [Google Scholar]
  155. van der Riet, W.B.; Wight, A.W.; Cilliers, J.J.L.; Datel, J.M. Food Chemical Analysis of Tempeh Prepared from South African-Grown Soybeans. Food Chem. 1987, 25, 197–206. [Google Scholar] [CrossRef]
  156. Ruiz-Terán, F.; Owens, J.D. Chemical and Enzymic Changes During the Fermentation of Bacteria-Free Soya Bean Tempe. J. Sci. Food Agric. 1996, 71, 523–530. [Google Scholar] [CrossRef]
  157. Rizal, S.; Kustyawati, M.E.; Murhadi; Hasanudin, U. The Growth of Yeast and Fungi, the Formation of β-Glucan, and the Antibacterial Activities during Soybean Fermentation in Producing Tempeh. Int. J. Food Sci. 2021, 2021, 6676042. [Google Scholar] [CrossRef] [PubMed]
  158. Tamam, B.; Syah, D.; Suhartono, M.T.; Kusuma, W.A.; Tachibana, S.; Lioe, H.N. Proteomic Study of Bioactive Peptides from Tempe. J. Biosci. Bioeng. 2019, 128, 241–248. [Google Scholar] [CrossRef]
  159. Rachmawati, P.A.; Afifah, D.N.; Rustanti, N.; Anjani, G.; Juniarto, A.Z. The Effect of Tempeh Gembus on Malondialdehyde and Superoxide Dismutase Enzyme Levels in Rats with Diet-Induced Metabolic Syndrome. J. Biomed. Transl. Res. 2022, 8, 91–98. [Google Scholar] [CrossRef]
  160. Watanabe, N.; Fujimoto, K.; Aoki, H. Antioxidant Activities of the Water-Soluble Fraction in Tempeh-like Fermented Soybean (GABA-Tempeh). Int. J. Food Sci. Nutr. 2007, 58, 577–587. [Google Scholar] [CrossRef]
  161. Astawan, M.; Rahmawati, I.S.; Cahyani, A.P.; Wresdiyati, T.; Putri, S.P.; Fukusaki, E. Comparison Between the Potential of Tempe Flour Made from Germinated and Nongerminated Soybeans in Preventing Diabetes Mellitus. HAYATI J. Biosci. 2020, 27, 16. [Google Scholar] [CrossRef]
  162. Blandino, G.; Inturri, R.; Lazzara, F.; Di Rosa, M.; Malaguarnera, L. Impact of Gut Microbiota on Diabetes Mellitus. Diabetes Metab. 2016, 42, 303–315. [Google Scholar] [CrossRef] [PubMed]
  163. Chan, E.W.C.; Wong, S.K.; Kezuka, M.; Oshiro, N.; Chan, H.T. Natto and Miso: An Overview on Their Preparation, Bioactive Components Andhealth-Promoting Effects. Food Res. 2021, 5, 446–452. [Google Scholar] [CrossRef]
  164. Kiuchi, K. Miso & Natto. Food Cult. 2001, 3, 7–10. [Google Scholar]
  165. Afzaal, M.; Saeed, F.; Islam, F.; Ateeq, H.; Asghar, A.; Shah, Y.A.; Ofoedu, C.E.; Chacha, J.S. Nutritional Health Perspective of Natto: A Critical Review. Biochem. Res. Int. 2022, 2022, 5863887. [Google Scholar] [CrossRef]
  166. Lan, G.; Li, C.; He, L.; Zeng, X.; Zhu, Q. Effects of Different Strains and Fermentation Method on Nattokinase Activity, Biogenic Amines, and Sensory Characteristics of Natto. J. Food Sci. Technol. 2020, 57, 4414–4423. [Google Scholar] [CrossRef]
  167. de Melo, F.C.B.C.; Zaia, C.T.B.V.; Celligoi, M.A.P.C. Levan from Bacillus subtilis Natto: Its Effects in Normal and in Streptozotocin-Diabetic Rats. Braz. J. Microbiol. 2012, 43, 1613–1619. [Google Scholar] [CrossRef]
  168. Kubo, Y.; Rooney, A.P.; Tsukakoshi, Y.; Nakagawa, R.; Hasegawa, H.; Kimura, K. Phylogenetic Analysis of Bacillus Subtilis Strains Applicable to Natto (Fermented soybean) Production. Appl. Environ. Microbiol. 2011, 77, 6463–6469. [Google Scholar] [CrossRef]
  169. Li, D.; Hou, L.; Hu, M.; Gao, Y.; Tian, Z.; Fan, B.; Li, S.; Wang, F. Recent Advances in Nattokinase-Enriched Fermented Soybean Foods: A Review. Foods 2022, 11, 1867. [Google Scholar] [CrossRef]
  170. Wang, L.; Chen, S.; Yu, B. Poly-γ-Glutamic Acid: Recent Achievements, Diverse Applications and Future Perspectives. Trends Food Sci. Technol. 2022, 119, 1–12. [Google Scholar] [CrossRef]
  171. Li, Y.; Zhang, W.; Tang, C.; Wang, C.; Liu, C.; Chen, Q.; Yang, K.; Gu, Y.; Lei, P.; Xu, H.; et al. Antidiabetic Effects and Mechanism of γ-Polyglutamic Acid on Type II Diabetes Mice. Int. J. Biol. Macromol. 2024, 261, 129809. [Google Scholar] [CrossRef] [PubMed]
  172. Lee, E.-H.; Son, W.-C.; Lee, S.-E.; Kim, B.-H. Anti-Obesity Effects of Poly-γ-Glutamic Acid with or without Isoflavones on High-Fat Diet Induced Obese Mice. Biosci. Biotechnol. Biochem. 2013, 77, 1694–1702. [Google Scholar] [CrossRef] [PubMed]
  173. Tamura, M.; Hori, S.; Inose, A.; Kobori, M. Effects of γ-Polyglutamic Acid on Blood Glucose and Caecal Short Chain Fatty Acids in Adult Male Mice. Food Nutr. Sci. 2020, 11, 8–22. [Google Scholar] [CrossRef]
  174. Keziah, S.M.; Devi, C.S. Fibrinolytic and ACE Inhibitory Activity of Nattokinase Extracted from Bacillus subtilis VITMS 2: A Strain Isolated from Fermented Milk of Vigna Unguiculata. Protein J. 2021, 40, 876–890. [Google Scholar] [CrossRef]
  175. Murakami, K.; Yamanaka, N.; Ohnishi, K.; Fukayama, M.; Yoshino, M. Inhibition of Angiotensin I Converting Enzyme by Subtilisin NAT (Nattokinase) in Natto, a Japanese Traditional Fermented Food. Food Funct. 2012, 3, 674–678. [Google Scholar] [CrossRef] [PubMed]
  176. Jensen, G.S.; Lenninger, M.; Ero, M.P.; Benson, K.F. Consumption of Nattokinase Is Associated with Reduced Blood Pressure and von Willebrand Factor, a Cardiovascular Risk Marker: Results from a Randomized, Double-Blind, Placebo-Controlled, Multicenter North American Clinical Trial. Integr. Blood Press. Control 2016, 9, 95–104. [Google Scholar] [CrossRef]
  177. Kim, J.Y.; Gum, S.N.; Paik, J.K.; Lim, H.H.; Kim, K.-C.; Ogasawara, K.; Inoue, K.; Park, S.; Jang, Y.; Lee, J.H. Effects of Nattokinase on Blood Pressure: A Randomized, Controlled Trial. Hypertens. Res. 2008, 31, 1583–1588. [Google Scholar] [CrossRef] [PubMed]
  178. Wu, D.-J.; Lin, C.-S.; Lee, M.-Y. Lipid-Lowering Effect of Nattokinase in Patients with Primary Hypercholesterolemia. Acta Cardiol. Sin. 2009, 25, 26–30. [Google Scholar]
  179. Sun, R.; Niu, H.; Li, Y.; Sun, M.; Hua, M.; Miao, X.; Su, Y.; Wang, J.; Li, D.; Wang, Y. Fermented Natto Powder Alleviates Obesity by Regulating LXR Pathway and Gut Microbiota in Obesity Rats. J. Appl. Microbiol. 2024, 135, lxae003. [Google Scholar] [CrossRef]
  180. Wang, P.; Gao, X.; Li, Y.; Wang, S.; Yu, J.; Wei, Y. Bacillus Natto Regulates Gut Microbiota and Adipose Tissue Accumulation in a High-Fat Diet Mouse Model of Obesity. J. Funct. Foods 2020, 68, 103923. [Google Scholar] [CrossRef]
  181. Araki, R.; Fujie, K.; Yuine, N.; Watabe, Y.; Maruo, K.; Suzuki, H.; Hashimoto, K. The Possibility of Suppression of Increased Postprandial Blood Glucose Levels by Gamma-Polyglutamic Acid-Rich Natto in the Early Phase after Eating: A Randomized Crossover Pilot Study. Nutrients 2020, 12, 915. [Google Scholar] [CrossRef] [PubMed]
  182. Araki, R.; Yamada, T.; Maruo, K.; Araki, A.; Miyakawa, R.; Suzuki, H.; Hashimoto, K. Gamma-Polyglutamic Acid-Rich Natto Suppresses Postprandial Blood Glucose Response in the Early Phase after Meals: A Randomized Crossover Study. Nutrients 2020, 12, 2374. [Google Scholar] [CrossRef]
  183. Matsumoto, Y.; Takahashi, M.; Sekimizu, K. Polysaccharides of a Fermented Food, Natto, Suppress Sucrose-Induced Hyperglycemia in an in Vivo Evaluation System and Inhibit Glucose Uptake by Human Intestinal Cells. Drug Discov. Ther. 2020, 14, 8–13. [Google Scholar] [CrossRef]
  184. Sato, K.; Miyasaka, S.; Tsuji, A.; Tachi, H. Isolation and Characterization of Peptides with Dipeptidyl Peptidase IV (DPPIV) Inhibitory Activity from Natto Using DPPIV from Aspergillus oryzae. Food Chem. 2018, 261, 51–56. [Google Scholar] [CrossRef]
  185. Sun, R.; Li, D.; Sun, M.; Miao, X.; Jin, X.; Xu, X.; Su, Y.; Xu, H.; Wang, J.; Niu, H. Bacillus Natto Ameliorates Obesity by Regulating PI3K/AKT Pathways in Rats. Biochem. Biophys. Res. Commun. 2022, 603, 160–166. [Google Scholar] [CrossRef]
  186. Zhang, L.; Wu, J.; Xu, P.; Guo, S.; Zhou, T.; Li, N. Soy Protein Degradation Drives Diversity of Amino-Containing Compounds via Bacillus Subtilis Natto Fermentation. Food Chem. 2022, 388, 133034. [Google Scholar] [CrossRef]
  187. Tamang, J.P.; Das, S.; Kharnaior, P.; Pariyar, P.; Thapa, N.; Jo, S.-W.; Yim, E.-J.; Shin, D.-H. Shotgun Metagenomics of Cheonggukjang, a Fermented Soybean Food of Korea: Community Structure, Predictive Functionalities and Amino Acids Profile. Food Res. Int. 2022, 151, 110904. [Google Scholar] [CrossRef]
  188. Kim, E.J.; Hong, J.Y.; Shin, S.R.; Moon, Y.-S.; Yoon, K. Analysis of the Taste Components and Antioxidant Properties of Cheonggukjang Containing Korean Red Ginseng. Food Sci. Biotechnol. 2009, 18, 53–59. [Google Scholar]
  189. Jeon, A.R.; Lee, J.H.; Mah, J.-H. Biogenic Amine Formation and Bacterial Contribution in Cheonggukjang, a Korean Traditional Fermented Soybean Food. LWT 2018, 92, 282–289. [Google Scholar] [CrossRef]
  190. Kim, H.-J.; Hwang, J.-T.; Kim, M.J.; Yang, H.-J.; Sung, M.J.; Kim, S.-H.; Park, S.; Gu, E.-J.; Park, Y.; Kwon, D.Y. The Inhibitory Effect of Saponin Derived from Cheonggukjang on Adipocyte Differentiation In Vitro. Food Sci. Biotechnol. 2014, 23, 1273–1278. [Google Scholar] [CrossRef]
  191. Cho, K.M.; Lim, H.-J.; Kim, M.-S.; Kim, D.S.; Hwang, C.E.; Nam, S.H.; Joo, O.S.; Lee, B.W.; Kim, J.K.; Shin, E.-C. Time Course Effects of Fermentation on Fatty Acid and Volatile Compound Profiles of Cheonggukjang Using New Soybean Cultivars. J. Food Drug Anal. 2017, 25, 637–653. [Google Scholar] [CrossRef] [PubMed]
  192. Kim, S.-Y.; Kim-Eun, H.; Kim, Y.-S. The Potentials of Bacillus licheniformis Strains for Inhibition of B. cereus Growth and Reduction of Biogenic Amines in Cheonggukjang (Korean Fermented Unsalted Soybean Paste). Food Control 2017, 79, 87–93. [Google Scholar] [CrossRef]
  193. Kim, D.; Jin, Y.H.; Mah, J.-H. Biogenic Amine Reduction by Food Additives in Cheonggukjang, a Korean Fermented Soybean Paste, Fermented with Tyramine-Producing Heterogeneous Bacterial Species. Heliyon 2024, 10, e26135. [Google Scholar] [CrossRef]
  194. Kim, M.-H.; Kim, S.-Y.; Ko, J.-M.; Jeong, D.-Y.; Kim, Y.-S. Biological Activities of Cheonggukjang Prepared with Several Soybean Cultivars. Food Sci. Biotechnol. 2012, 21, 475–483. [Google Scholar] [CrossRef]
  195. Kwon, D.Y.; Jang, J.S.; Hong, S.M.; Lee, J.E.; Sung, S.R.; Park, H.R.; Park, S. Long-Term Consumption of Fermented Soybean-Derived Chungkookjang Enhances Insulinotropic Action Unlike Soybeans in 90% Pancreatectomized Diabetic Rats. Eur. J. Nutr. 2007, 46, 44–52. [Google Scholar] [CrossRef]
  196. Hwang, J.W.; Do, H.J.; Kim, O.Y.; Chung, J.H.; Lee, J.-Y.; Park, Y.S.; Hwang, K.Y.; Seong, S.-I.; Shin, M.-J. Fermented Soy Bean Extract Suppresses Differentiation of 3T3-L1 Preadipocytes and Facilitates Its Glucose Utilization. J. Funct. Foods 2015, 15, 516–524. [Google Scholar] [CrossRef]
  197. Yang, H.J.; Kwon, D.Y.; Moon, N.R.; Kim, M.J.; Kang, H.J.; Jung, D.Y.; Park, S. Soybean Fermentation with Bacillus Licheniformis Increases Insulin Sensitizing and Insulinotropic Activity. Food Funct. 2013, 4, 1675. [Google Scholar] [CrossRef] [PubMed]
  198. Lee, S.-Y.; Park, S.-L.; Hwang, J.-T.; Yi, S.-H.; Nam, Y.-D.; Lim, S.-I. Antidiabetic Effect of Morinda citrifolia (Noni) Fermented by Cheonggukjang in KK-Ay Diabetic Mice. Evid.-Based Complement. Altern. Med. 2012, 2012, 163280. [Google Scholar] [CrossRef] [PubMed]
  199. Nam, Y.-D.; Park, S.; Lim, S.-I. Microbial Composition of the Korean Traditional Food “Kochujang” Analyzed by a Massive Sequencing Technique. J. Food Sci. 2012, 77, M250–M256. [Google Scholar] [CrossRef]
  200. Das, D.; Wann, S.B.; Kalita, J.; Manna, P. Insight into the Efficacy Profile of Fermented Soy Foods against Diabetes. Food Biosci. 2023, 53, 102665. [Google Scholar] [CrossRef]
  201. Jeong, S.-J.; Yang, H.-J.; Yang, H.G.; Ryu, M.S.; Ha, G.; Jeong, D.Y.; Park, S. Inverse Association of Daily Fermented Soybean Paste (“Jang”) Intake with Metabolic Syndrome Risk, Especially Body Fat and Hypertension, in Men of a Large Hospital-Based Cohort. Front. Nutr. 2023, 10, 1122945. [Google Scholar] [CrossRef]
  202. Choi, Y.-S.; Lee, B.-H.; Kim, J.-H.; Kim, N.-S. Concentration of Phytoestrogens in Soybeans and Soybean Products in Korea. J. Sci. Food Agric. 2000, 80, 1709–1712. [Google Scholar] [CrossRef]
  203. Panchal, S.K.; Bliss, E.; Brown, L. Capsaicin in Metabolic Syndrome. Nutrients 2018, 10, 630. [Google Scholar] [CrossRef]
  204. Ahn, I.-S.; Do, M.-S.; Kim, S.-O.; Jung, H.-S.; Kim, Y.-I.; Kim, H.-J.; Park, K.-Y. Antiobesity Effect of Kochujang (Korean Fermented Red Pepper Paste) Extract in 3T3-L1 Adipocytes. J. Med. Food 2006, 9, 15–21. [Google Scholar] [CrossRef]
  205. Yang, H.J.; Kim, M.J.; Kim, K.S.; Lee, J.E.; Hong, S.P. In Vitro Antidiabetic and Antiobesity Activities of Traditional Kochujang and Doenjang and Their Components. Prev. Nutr. Food Sci. 2019, 24, 274–282. [Google Scholar] [CrossRef]
  206. Lee, H.Y.; Cho, D.Y.; Jung, J.G.; Kim, M.J.; Jeong, J.B.; Lee, J.H.; Lee, G.Y.; Jang, M.Y.; Lee, J.H.; Haque, M.A.; et al. Comparisons of Physicochemical Properties, Bacterial Diversities, Isoflavone Profiles and Antioxidant Activities on Household and Commercial Doenjang. Molecules 2023, 28, 3516. [Google Scholar] [CrossRef]
  207. Jeong, S.-J.; Ryu, M.-S.; Yang, H.-J.; Wu, X.-H.; Jeong, D.-Y.; Park, S.-M. Bacterial Distribution, Biogenic Amine Contents, and Functionalities of Traditionally Made Doenjang, a Long-Term Fermented Soybean Food, from Different Areas of Korea. Microorganisms 2021, 9, 1348. [Google Scholar] [CrossRef] [PubMed]
  208. Yi, S.-H.; Hong, S.-P. Characteristics of Bacterial Strains with Desirable Flavor Compounds from Korean Traditional Fermented Soybean Paste (Doenjang). Molecules 2021, 26, 5067. [Google Scholar] [CrossRef] [PubMed]
  209. Jo, E.; Lee, H.; Song, Y.; Cha, J. Taxonomic Variations of Bacterial and Fungal Communities Depending on Fermentation Temperature in Traditional Korean Fermented Soybean Food, Doenjang. J. Microbiol. Biotechnol. 2024, 34, 863–870. [Google Scholar] [CrossRef] [PubMed]
  210. Jakubczyk, A.; Karaś, M.; Złotek, U.; Szymanowska, U.; Baraniak, B.; Bochnak, J. Peptides Obtained from Fermented Faba Bean Seeds (Vicia faba) as Potential Inhibitors of an Enzyme Involved in the Pathogenesis of Metabolic Syndrome. LWT 2019, 105, 306–313. [Google Scholar] [CrossRef]
  211. Torino, M.I.; Limón, R.I.; Martínez-Villaluenga, C.; Mäkinen, S.; Pihlanto, A.; Vidal-Valverde, C.; Frias, J. Antioxidant and Antihypertensive Properties of Liquid and Solid State Fermented Lentils. Food Chem. 2013, 136, 1030–1037. [Google Scholar] [CrossRef] [PubMed]
  212. Yeap, S.K.; Mohd Ali, N.; Mohd Yusof, H.; Alitheen, N.B.; Beh, B.K.; Ho, W.Y.; Koh, S.P.; Long, K. Antihyperglycemic Effects of Fermented and Nonfermented Mung Bean Extracts on Alloxan-Induced-Diabetic Mice. J. Biomed. Biotechnol. 2012, 2012, 285430. [Google Scholar] [CrossRef]
  213. Yeap, S.K.; Beh, B.K.; Ho, W.Y.; Mohd Yusof, H.; Mohamad, N.E.; Ali, N.M.; Jaganath, I.B.; Alitheen, N.B.; Koh, S.P.; Long, K. In Vivo Antioxidant and Hypolipidemic Effects of Fermented Mung Bean on Hypercholesterolemic Mice. Evid.-Based Complement. Altern. Med. 2015, 2015, 508029. [Google Scholar] [CrossRef]
  214. Lin, N.-N.; Lee, Y.-F.; Chi, Y.-J.; Wang, M.-F.; Chan, Y.-C.; Chan, K.-C.; Chen, Y.-J.; Chiu, Y.-T. Bacillus subtilis -Fermented Red Bean (Red Bean Natto) Reduces Hyperlipidemia Levels in Hamsters Fed an Atherogenic Diet: Red Bean Natto Reduces Hyperlipidemia in Hamsters. J. Food Biochem. 2017, 41, e12264. [Google Scholar] [CrossRef]
  215. Pino, A.; Vaccalluzzo, A.; Solieri, L.; Romeo, F.V.; Todaro, A.; Caggia, C.; Arroyo-López, F.N.; Bautista-Gallego, J.; Randazzo, C.L. Effect of Sequential Inoculum of Beta-Glucosidase Positive and Probiotic Strains on Brine Fermentation to Obtain Low Salt Sicilian Table Olives. Front. Microbiol. 2019, 10, 174. [Google Scholar] [CrossRef]
  216. Vaccalluzzo, A.; Pino, A.; De Angelis, M.; Bautista-Gallego, J.; Romeo, F.V.; Foti, P.; Caggia, C.; Randazzo, C.L. Effects of Different Stress Parameters on Growth and on Oleuropein-Degrading Abilities of Lactiplantibacillus plantarum Strains Selected as Tailored Starter Cultures for Naturally Table Olives. Microorganisms 2020, 8, 1607. [Google Scholar] [CrossRef]
  217. Lalas, S.; Athanasiadis, V.; Gortzi, O.; Bounitsi, M.; Giovanoudis, I.; Tsaknis, J.; Bogiatzis, F. Enrichment of Table Olives with Polyphenols Extracted from Olive Leaves. Food Chem. 2011, 127, 1521–1525. [Google Scholar] [CrossRef]
  218. Bahuguna, A.; Shukla, S.; Lee, J.S.; Bajpai, V.K.; Kim, S.-Y.; Huh, Y.S.; Han, Y.-K.; Kim, M. Garlic Augments the Functional and Nutritional Behavior of Doenjang, a Traditional Korean Fermented Soybean Paste. Sci. Rep. 2019, 9, 5436. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Fermentation classification according to technology, type of microorganisms carrying out the fermentation, and product profile.
Figure 1. Fermentation classification according to technology, type of microorganisms carrying out the fermentation, and product profile.
Nutrients 17 01989 g001
Figure 2. Microbial metabolites in fermented fruits, vegetables, and legumes. ↓, decrease; ⊕, improvement; ⊖, inhibition; ACE, angiotensin-converting enzyme; Akt, protein kinase B; AMPK, AMP-activated protein kinase; CPT-1, carnitine palmitoyltransferase 1; DPP IV, dipeptidyl peptidase 4; GABA, γ-aminobutyric acid; HDMPPA, 3-(40-hydroxyl-30,50-dimethoxyphenyl) propionic acid; PI3K, phosphatidylinositol 3-kinase; PPAR, peroxisome proliferator-activated receptor; SREBP-1, sterol regulatory element-binding protein 2; γ-PGA, γ-polyglutamic acid.
Figure 2. Microbial metabolites in fermented fruits, vegetables, and legumes. ↓, decrease; ⊕, improvement; ⊖, inhibition; ACE, angiotensin-converting enzyme; Akt, protein kinase B; AMPK, AMP-activated protein kinase; CPT-1, carnitine palmitoyltransferase 1; DPP IV, dipeptidyl peptidase 4; GABA, γ-aminobutyric acid; HDMPPA, 3-(40-hydroxyl-30,50-dimethoxyphenyl) propionic acid; PI3K, phosphatidylinositol 3-kinase; PPAR, peroxisome proliferator-activated receptor; SREBP-1, sterol regulatory element-binding protein 2; γ-PGA, γ-polyglutamic acid.
Nutrients 17 01989 g002
Table 1. Characteristics of microbial communities and main biologically active compounds in fermented fruits, vegetables, and legumes.
Table 1. Characteristics of microbial communities and main biologically active compounds in fermented fruits, vegetables, and legumes.
ProductRaw IngredientCharacteristic MicroorganismsMain Bioactive CompoundsCountry/Region of OriginReferences
Table olivesOlive fruitsBacteria: L. acidipiscis, L. brevis, L. casei, L. coryniformis, L. fermentum, L. helveticus, L. paracasei, L. parafarraginis, L. paraplantarum, L. pentosus, L. plantarum, L. rhamnosus, E. faecalis, E. faecium, Lc. formosensis, Lc. lactis, Leu. mesenteroides, Ped. acidilactici, Ped. damnosus, S. inulinus, S. terrae, St. thermophilus, W. paramesenteroides, W. hellenica
Yeasts: Wickerhamomyces anomalus, Wickerhamomyces sydowiorum, Saccharomyces cerevisiae, Pichia kluyveri, Pichia membranifaciens, Brettanomyces custersianus, Candida orthopsilosis, Candida tropicalis, Debaryomyces hansenii
Phenolic compounds: hydroxytyrosol, tyrosol, rutin, luteolin, cyanidin, and delphinidin glucosides (only in black olives)
Iridoids: oleuropein, verbascoside
Organic acids: lactic acid
SCFAs: acetic acid, butyric acid
Triterpenic acids: maslinic acid, oleanolic acid
MUFA: Oleic acid
Sterols: β-sitosterol, Δ5-avenasterol
Mediterranean countries (Spain, Portugal, Greece, and Italy)[23,27,28,29,30]
CaperCaper berriesBacteria: L. plantarum, L. Paraplantarum, L. Pentosus, L. Fermentum, L. Brevis, Ped. Pentosaceus, Ped. Acidilactici, E. faecium
Yeasts: Aureobasidium pullulans
Phenolic compounds: quercetin, quercetin glycosides (mainly rutin), kaempferol, kaempferol glycosides, isorhamnetin, isorhamnetin glycosides, myricetin, ferulic acid, vanillic acid, epicatechin Mediterranean countries[31,32,33]
KimchiChinese cabbage with other vegetables and condimentsBacteria: Leu. mesenteroides, Leu. gasicomitatum, Leu. gasicomitatum, Leu. kimchii, Leu. miyukkimchii, L. brevis, L. plantarum, L. kimchii, L. kimchiensis, L. koreensis, W. koreensis, Lc. kimchii, Tetragenococcus spp., St. faecalis, Ped. cerevisiae, Bacillus spp.
Yeasts: Lodderomyces spp., Candida spp., Trichosporon spp., Saccharomyces spp., Pichia spp.
Sulfur compounds: S-methlycysteinsulfoxide, S-allylcysteinsulfoxide
Sterols: α-sitosterol
Amino acids: ornithine
Others: capsaicin, HDMPPA, gingerol
Korea[34,35,36]
Sauerkraut/
Fermented cabbage
CabbageBacteria: L. plantarum, Leu. mesenteroides, Ped. pentosaceus, Levilactobacillus spp., Paucilactobacillus spp., Secundilactobacillus spp.
Yeasts: Cryptococcus macerans, Debaryomyces hansenii, Pichia fermentans, Wickerhamomyces anomalus, Rhodotorula mucilaginosa
Organic acids: lactic acid, malic acid
SCFAs: acetic acid, propionic acid, butyric acid
Biogenic amines: tyramine, putrescine
Amino acids: alanine, leucine
Exopolysaccharides
Esters: ethyl acetate, ethyl lactate
Pyrazines: 2,5-dimethylpyrazine
Sulfur compounds: allyl isothiocyanate, dimethyl sulfide
Terpenes: geranyl acetone
Others: dimethyl sulfoxide, uracil, ascorbinogen
Europe, USA, China[37,38,39,40,41,42]
NattoSoybeanBacillus subtilis var. nattoPeptides and amino acids
Exopolysaccharides: levan
Isoflavones: daidzein, genistein, glycitein, and corresponding β-glucosides
Ketones: acetoin
Pyrazines: di, tri, tetramethyl pyrazines
Biogenic amines: spermine, followed by spermidine, tyramine
SCFAs: acetic acid, isobutyric acid, isovaleric acid
Others: γ-PGA, phenol, 2-metoxyphenol
China, Japan[43]
TempehSoybeanBacteria: E. cecorum, L. agilis, L. fermentum, L. mucosae, L. delbrucki, Acetobacter indonesiensis, Weisella spp., Enterococcus spp., Leuconostoc spp., Paenibacillus spp., Bacillus spp.
Yeasts: Pichia guilliermondii, Candida tropicalis, Pichia norvegensis, Sporopachydermia lactativora, Trichosporon asahii
Molds: R. microsporus, R. delemar, R. oligosporus, R. oryzae, R. stolonifer, Mucor spp., Rhizomucor spp.
Isoflavones: daidzein, genistein, glycitein, and corresponding β-glucosides
Peptides and amino acids
SCFAs
Others: GABA
Indonesia (also introduced in Japan, India, Europe, and Africa)[44,45,46,47,48,49,50]
CheonggukjangSoybeanBacteria: B. piscis, B. coagulans, B. carboniphilus, B. hisashii, Ab. aneurinilyticus, S. equorum, B. subtilis, B. licheniformis, B. amylolquefaciens, B. haynessi, B. velazensisBiogenic amines: tyramine, β-phenylethylamine, putrescine
Saponins: soyasapogenol A and B
Ketones: 1,3-diphenyl-2-propanone
Organic acids: lactic acid, 2-hydroxyglutaric acid
Pyrazines
Aromatic compounds: 4
-(nonafluoro-tert-butyl) nitrobenzene
Isoflavones: daidzein, genistein, glycitein, and corresponding β-glucosides
Others: GABA, γ-PGA
Korea[51,52,53,54]
DoenjangSoybeanBacteria: B. paralicheniformis, B. subtilis, B. acidicola, B. dabaoshanensis, B. idriensis, B. carboniphilus, B. aerius, B. crescens, E. hirae, E. phoeniculicola, Ped. acidilacti, E. faecalis, Ped. claussenii, B. licheniformis, B. athrophaeus, Enterobacter soli, Lentibacillus sp., Enterobacter sp.
Yeasts: Zygosaccharomyces pseudorouxii, Zygosaccharomyces mellis, Candida versatilis, Ogatea polymorpha, Saccharomyces cerevisiae
Isoflavones: daidzein, genistein, glycitein, and corresponding β-glucosides
Amino acids: glutamic acid
Fatty acids: isovaleric acid,
Volatile compounds: 3-methyl butanal, benzeneacetaldehyde, α-curcumene, β-sesquiphellandrene, diallyl disulfide
Pyrazines
Others: GABA
Korea[55,56]
KochujangSoybeanBacteria: B. amyloquefaciens, B. carboniphilus, B. circulans, B. coagulans, B. lentus, B. licheniformis, B. megaterium, B. pumilus, B. stearothermophilus, B. sonorensis, B. subtilis, B. thuringiensis, Aneurinibacillus thermoaerophilus, Brevibacillus borstelensis, E. faecalis, E. faecium, L. delbrucki, L. fermentum, L. fructivorans, L. gassei, L. halophilus, L. plantarum, L. salivarius, L. sakei, L. paracasei, W. confuse
Yeasts: Saccharomyces cerevisiae, Zygosaccharomyces rouxii
Isoflavones
Others: capsaicin
Korea[57,58,59,60]
Conclusions: The microbial communities of table olives, capers, kimchi, and sauerkraut consist mostly of LAB, including L. plantarum and Pediococcus spp., as well as yeasts. In fermented soybean products, mostly Bacillus species have been identified. In tempeh, molds such as Rhizopus spp. and Mucor spp. have also been identified.
The most frequently identified groups of bioactive compounds in fermented foods include organic acids, SCFAs, GABA, free amino acids, and biogenic amines. Olives and capers are dietary sources of phenolic compounds, primarily flavonoids. A characteristic group of compounds found exclusively in table olives are iridoids. Kimchi and sauerkraut are produced from fermented cabbage and, as a result, are rich in sulfur compounds. Fermented soybean products typically contain isoflavone aglycones (daidzein, genistein, glycitein), peptides, and amino acids. A unique and health-promoting compound, γ-PGA, has been reported in natto and cheonggukjang.
γ-PGA, γ-polyglutamic acid; GABA, γ-aminobutyric acid; SCFAs, short-chain fatty acids.
Table 2. Effects of fermented fruits, vegetables, and legumes on parameters related to metabolic syndrome.
Table 2. Effects of fermented fruits, vegetables, and legumes on parameters related to metabolic syndrome.
ProductnAnimals/
Patients
Length of StudyInterventionControlHealth-Promoting Effect 1References
Caper fruit pickle44Subjects with a BMI of 25–35 kg/m2 and NAFLD12 weeksCaper fruit pickle (40–50 g/day) and consultation with a nutritionistConsultation with a nutritionistAnti-obesity effect: ↓ BW, ↓ BMI (compared to baseline)
No hypolipidemic effect: Ø TC, Ø TG, Ø LDL, Ø HDL
[77]
Caper fruit pickle 44Subjects with a BMI of 25–35 kg/m2 and NAFLD12 weeksCaper fruit pickle (40–50 g/day) and consultation with a nutritionistConsultation with a nutritionistNo anti-inflammatory effect: Ø hs-CRP
Anti-obesity effect: ↓ waist circumference
Hypolipidemic effect: ↓ LDL/HDL, ↓TG/HDL, ↓ TC/HDL (compared to baseline)
No anti-diabetic effect: Ø insulin, Ø HOMA-IR
[82]
Caper fruit pickle 60Subjects newly diagnosed with
hyperlipidemia and prescribed low-dose
atorvastatin
8 weeksCaper fruit pickle (40–50 g/day) and 10 mg atorvastatin10 mg atorvastatinHypolipidemic effect: ↓ TC, ↓ LDL, ↓ TG, ↑ HDL[83]
Kimchi22Obese and overweight subjects (crossover study)4 weeksKimchi (300 g/day)BaselineAnti-inflammatory effect: Ø CRP, Ø IL-6, Ø TNF-α, ↓ MCP-1
Anti-obesity effect: ↓ BW, ↓ BMI, ↓ WHR, ↓ body fat, Ø adiponectin, ↓ leptin
Anti-diabetic effect: ↓ FBG, ↓ FBI,
No hypotensive effect: Ø systolic BP, Ø diastolic BP
Hypolipidemic effect: ↓ TC, Ø LDL, Ø HDL, Ø TG
[84]
Kimchi fermented with Weissella koreensis OK1-67Obese mice12 weeksHFD with kimchi powder (3%)HFDAnti-obesity effect: ↓ BW, ↓ epididymal adipose tissue, ↓ leptin
Anti-diabetic effect: ↓ insulin
Hypolipidemic effect: ↓ TC, Ø TG
[85]
Kimchi21Prediabetic subjects (crossover study)8 weeksKimchi (300 g/day)BaselineNo anti-inflammatory effect: Ø IL-1β, Ø IL-6, Ø IL-10, Ø TNF-α, Ø MCP-1, Ø CRP, Ø FGF-21
Anti-obesity effect: ↓ BW, ↓ BMI, ↓ WC, ↓ body fat (%, kg), Ø adiponectin
Anti-diabetic effect: ↓ HbA1c, Ø FBG, ↓ FBI, ↓ HOMA-IR, ↑ Matsuda Index, ↑ QUICKI, ↑ DI, Ø IGI
Hypotensive effect: ↓ systolic BP, ↓ diastolic BP
[86]
Kimchi100Healthy subjects1 weekKimchi (210 g/day)Kimchi (15 g/day) Antioxidative effect: ↑ TAC (statistically significant in both groups, but not between groups)
Anti-diabetic effect: ↓ FBG (statistically significant in both groups and between groups)
Hypolipidemic effect: ↓ TC, ↓ LDL, ↓ TG (statistically significant in both groups, but not between groups)
[36]
Kimchi28Healthy subjects4 weeksStandardized or functional kimchi with additional condiments and probiotics (210 g/day)BaselineAnti-inflammatory effect: ↓ IL-6, Ø hs- CRP, Ø MCP-1, Ø TNF-α (both standardized and functional kimchi)
Anti-obesity effect: ↓ body fat (%), ↑ skeletal muscle mass, ↑ adiponectin, Ø BW, Ø WHR, Ø BMI, Ø body fat (kg), Ø leptin (statistically significant only in functional kimchi group)
Hypolipidemic effect: ↓ LDL, ↑ HDL (both groups), ↓ TG, ↓ TC (only in functional kimchi group)
[16]
Cheonggukjang (CGJ)10090% of pancreatectomized diabetic rats8 weeksSoybean or CGJ (amount not given)Diabetic rats, diabetic rats with rosiglitazone, non-diabetic ratsNo anti-obesity effect: Ø BW, Ø food intake
Anti-diabetic effect: ↓ glucose, ↓ insulin, improved OGTT, Ø β cell area (CGJ and soybean groups), ↓ β cell size and mass (only CGJ group), Ø β cells apoptosis
[87]
Cheonggukjang30C57BL/KsJ-db/db mice6 weeksDiet containing CGJ (5 g/100 g)Diabetic mice, diabetic mice with rosiglitazone Anti-obesity effect: ↓ BW, ↓ weight gain, ↓ food efficiency ratio, Ø food intake
Anti-diabetic effect: ↓ glucose, ↓ HbA1c, Ø leptin, Ø insulin, ↓ glucagon, ↑ insulin (pancreatic tissue), Ø glucagon (pancreatic tissue)
[88]
Cheonggukjang 30Mice12 weeksHFD with CGJ (40%)Normal diet, HFDAnti-obesity effect: ↑ food intake, ↓ weight gain, ↓ epididymal fat, ↓ back fat
Hypolipidemic effect: ↓ TC, ↓ TG
[89]
Cheonggukjang 38Obese mice13 weeksHFD with 30% cooked soybean powder or 30% CGJ powderNormal diet, HFDHypolipidemic effect: Ø TG, ↓ TC (significant only for HFD compared to HFD + 30% CGJ powder)[90]
Cheonggukjang32Rats4 weeksHFD with CGJ (20%) or CGJ made from soybean germinated under light or dark conditions (20%)HFDNo anti-obesity effect: Ø BW, Ø food intake, Ø food efficiency ratio
Hypolipidemic effect: Ø TC, ↓ LDL, ↓ TG, ↑ HDL (only for CGJ from soybean germinated under light conditions)
[91]
Cheonggukjang80Diabetic rats (induced by partial pancreatectomy)8 weeksHFD with cooked soybeans (10%) or traditional CGJ or CGJ fermented with a starter (B. lichemiformis) (10%)Nondiabetic rats, diabetic ratsAnti-obesity effect: ↓ BW (only soybean), ↓ epididymal fat, ↓ caloric intake (all groups), ↓ leptin (only soybean)
Anti-diabetic effect: ↓ FBG (all treatments), ↑ insulin, ↑ β cell area (both CGJ groups), ↓ β cell size (all groups), ↓ β cell apoptosis (all groups)
[92]
Cheonggukjang87Overweight/obese subjects (BMI ≥ 23 kg/m2 or WC ≥ 80 cm for women or ≥90 cm for men) (crossover study)12 weeksCGJ fermented with B. licheniformis (70 g/day)Baseline, placeboAnti-inflammatory effect: ↓ hsCRP (women, compared to baseline)
Anti-obesity effect: Ø BW, Ø BMI, Ø body fat (kg), Ø lean body mass, Ø WC, Ø HC, ↓ WHR (significant only for women compared between groups), ↓ body fat (%) (significant only for women, compared to baseline and placebo)
Hypolipidemic effect: ↑ TC (men, compared to baseline), Ø TC (women, compared to baseline), Ø LDL, ↑ TG (compared to baseline), Ø HDL, Ø FFA, ↑ ApoA1 (compared to baseline), ↓ ApoB (women, compared to baseline), ↓ ApoB/ApoA1 (compared to baseline)
[93]
Cheonggukjang40Obese mice13 weeksHFD with unfermented soybean (30%) or CGJ fermented with γ-PGA producing starter strain (B. licheniformis-67) (30%)Normal diet and HFDAnti-obesity effect: ↓ BW, ↓ weight gain, ↓ food efficiency ratio, ↓ leptin (significant compared to soybean and CGJ group), ↓ epidydymal fat (only CGJ group)
Anti-diabetic effect: ↓ FBG, improved OGTT (only in CGJ group), Ø insulin
Hypolipidemic effect: ↓TC (significant only for CGJ group), ↓ HDL, Ø TG (both soybean and CGJ groups)
[87]
Cheonggukjang 30Obese mice13 weeksHFD with CGJ (10%)Normal diet and HFDAnti-inflammatory effect: ↓ MCP-1, ↓ TNF-α mRNA expression
Anti-obesity effect: ↓ BW, ↓ weight gain, Ø food intake, ↓ food efficiency ratio, Ø epididymal fat, ↓ perirenal fat, ↓ leptin, ↑ adiponectin (all parameters significant compared to HFD, but leptin level also significant compared to baseline), ↓ adipocyte size
Anti-diabetic effect: ↓ glucose, ↓ insulin
Hypolipidemic effect: ↓ TC, ↓ TG
[94]
Cheonggukjang55Overweight/obese subjects with a BMI ≥ 25 kg/m212 weeksFreeze-dried CGJ (26 g/day) Baseline and placeboNo anti-obesity effect: Ø total fat, Ø visceral fat, Ø subcutaneous fat, Ø visceral subcutaneous ratio
Hypolipidemic effect: Ø TC, Ø TG, Ø LDL, Ø HDL, Ø FFA, Ø ApoA1, ↓ ApoB (significant compared to baseline and placebo), Ø ApoB/ApoA1
[95]
Cheonggukjang45Subject with impaired fasting blood glucose8 weeksCGJ (20 g/day) or CGJ with red ginseng (20 g/day) Placebo (starch 2 g/day)Antioxidative effect: ↓ TBARS
Anti-diabetic effect: ↓ FBG
Hypolipidemic: ↓ TC, ↓ LDL, Ø HDL, Ø lipoprotein (a), ↓ Apo B/ApoA1 (only CGJ group)
[96]
Cheonggukjang59Obese subjects with a BMI ≥ 25 kg/m28 weeksFreeze-dried traditional CGJ with a high microorganism content, with a low microorganism content, and commercial
CGJ (3 g/day)
Baseline No anti-inflammatory effect: Ø IL-6, Ø haptoglobin, Ø hs-CRP
No anti-obesity effect: Ø HC, Ø WHR, Ø VF, Ø SF, Ø V/S
No hypolipidemic effect: Ø TC, Ø LDL, Ø HDL
No anti-diabetic effect: Ø glucose, Ø insulin, Ø HOMA-IR, Ø QUICKI
(the same effect on each type of supplementation)
[97]
Tempeh48STZ-induced diabetic rats14 weeksSTZ + HFD with cooked soybean or tempeh or tempeh fermented with probiotics (L. plantarum and R. oligosporus) (40 mg/kg BW/day)Control diet, STZ + HFD or STZ + HFD + pioglitazoneAnti-diabetic effect: improved OGTT, ↓ AC glucose, ↓ HbA1C, ↓ insulin, ↓ HOMA-IR
Hypolipidemic effect: ↓ TC, ↓TG, ↓ LDL, ↓ FFA, ↑ HDL
[98]
Tempeh20STZ-induced rats30 daysTempeh powder (200 mg/kg BW/day)Nondiabetic rats, diabetic rats Anti-diabetic effect: ↓ insulitis, no effect on the diameter of pancreatic Langerhans islets[99]
Tempeh18Rats3 weeksHigh cholesterol diet and tempeh flour (0.95 g/100 g BW/day)Standard diet, high cholesterol dietAntioxidative effect: ↓ MDA
Anti-obesity effect: ↓ BW, Ø food intake
Hypolipidemic effect: ↓ TC, ↓ TG, ↑ HDL
[100]
Tempeh30STZ-induced rats4 weeksTempeh or tempeh fermented with fermented cassava tuber extract in amounts that provide 15 or 30% of proteinNondiabetic rats, diabetic rats Anti-diabetic effect: ↓ FBG (statistically significant compared to diabetic control, effect was slightly stronger according to tempeh fermented with cassava extract)[101]
Tempeh30STZ-induced diabetic mice3 weeksTempeh (10, 20, or 40 mg/100 g BW/day)Nondiabetic mice, diabetic mice, diabetic mice with metforminAnti-diabetic effect: ↓ blood glucose
Hypolipidemic effect: ↓ TC, ↓ LDL, ↓ TG, ↑ HDL
[102]
Tempeh fermented in both aerobic and anaerobic conditions20STZ-induced diabetic mice3 weeksTempeh (10, 20, or 40 mg/100 g BW/day)Nondiabetic mice, diabetic mice Anti-diabetic effect: ↓ blood glucose, ↑ insulin, ↓ insulin secretion (HOMA-β) (statistically significant compared to diabetic control, glucose level was statistically significant also compared to baseline)[103]
Tempeh18Db/db obese diabetic mice12 weeksTempeh (300 mg/kg or 600 mg/kg)Db/db obese diabetic miceAnti-obesity effect: ↓ BW (for 600 mg/kg, compared to baseline and 300 mg/kg)
Anti-diabetic effect: ↓ blood glucose
Hypolipidemic effect: ↓ lipid accumulation in adipocytes (for 600 mg)
[104]
Tempeh30Obese rats4 weeksHigh-fat sucrose diet and freeze-dried tempeh fermented with R. oligosporus (60 mg/kg BW) or R. oligosporus and L. rhamnosus GG co-fermented tempeh in dose 60 mg/kg BW or 120 mg/kg BWStandard diet, high-fat sucrose diet, and high-fat fructose diet with orlistat (120 mg/kg BW)Anti-inflammatory effect: ↓ hsCRP (all interventions compared to negative control)
Anti-obesity effect: ↓ BW (all interventions compared to negative control)
Hypolipidemic effect: ↓ TC, ↓ LDL, ↓ TG, ↑ HDL (all interventions compared to negative control)
[105]
Tempeh gembus41Women with hyperlipidemia2 weeksTempeh gembus (103 or 206 g/day) and nutrition educationNutrition education, baselineHypolipidemic effect: ↓ TC, ↓ LDL (significant only compared to baseline, no between groups), Ø TG, Ø HDL[106]
Tempeh40Obese women with BMI ≥ 25 kg/m24 weeksProcessed tempeh (150 g/day)ControlAnti-obesity effect: ↓ WC, Ø BW, Ø BMI
No anti-diabetic effect: Ø FBG
[107]
Tempeh35Patients with type 2 diabetes12 weeksFreeze-dried tempeh (2 g/day)BaselineHypolipidemic effect: ↓ TG, Ø TC, Ø LDL, Ø HDL
Anti-diabetic effect: ↓ HbA1c, Ø AC sugar
[108]
Tempeh24Subjects with TC ≥ 4.92 mmol/L6 weeksTempeh (66 g/day)Control group and baseline (n of subjects in control group = 3)Anti-obesity effect: ↓ BW
Hypolipidemic effect: ↓WC (statistically significant compared to baseline, no between groups); Ø fat (%), Ø visceral fat (%), Ø TC
[109]
Natto fractions18Rats3 weeksDiet containing 1% cholesterol and with 9% low-molecular-weight viscous substance from natto (LMWVS) or 9% soybean water extract (SWE) from soybean from nattoDiet with 1% cholesterolAni-oxidative effect: Ø Cu/Zn-SOD, Ø CAT, Ø GSH, ↓ TBARS, ↑ Mn-SOD (only LMWVS), ↑ GSH-Px (only SWE)
No anti-obesity effect: Ø BW
Hypolipidemic effect: Ø TC, Ø LDL, Ø HDL, Ø free cholesterol, Ø FFA, ↓ TG (both fractions)
[110]
Natto50Rats4 weeksDiet with 1% cholesterol and natto powder (750 mg/day or 1500 mg/day)Diet, diet with 1% cholesterol, diet with 1% cholesterol, and aspirin (100 mg/day)No anti-obesity effect: Ø BW
Hypolipidemic effect: Ø TG, ↓ TC (only group with supplementation in dose 1500 mg/day)
[111]
Natto30Mice4 weeksHFD with natto (2.5% or 5%) or soybean (2.5% or 5%)Control diet, HFDAntioxidative effect: ↓ TBARS
Anti-obesity effect: ↓ BW (natto 2.5%, natto 5%, soybean 5%), Ø food intake, ↓ total fat tissue
Anti-diabetic effect: ↓ glucose (natto 5%, soybean 2.5%, soybean 5%), ↓ insulin (natto 5%), ↓ HOMA-IR (natto 2.5%)
Hypolipidemic effect: Ø TG, ↓ TC (natto 2.5%, natto 5%, soybean 2.5%)
[112]
Natto21Mice6 weeksHFD with cooked soybean (15%) or tempeh (15%)HFDNo anti-obesity effect: Ø BW, Ø visceral fat, Ø food intake
Anti-diabetic effect: ↓ glucose (only the tempeh group compared to HFD)
Hypolipidemic effect: Ø TC, Ø FFA, Ø HDL, ↓ TG (only tempeh group compared to HFD)
[113]
Natto11Overweight subjects with impaired glucose tolerance (crossover study)2 weeksBreakfast consisting of white rice, natto, okra, and Japanese yamBreakfast consisted of white rice, boiled soybeans, potatoes, broccoli; baselineAntioxidative effect: ↓ MDA-LDL (significant between groups)
No anti-obesity effect: Ø BW, Ø adiponectin, Ø leptin
Anti-diabetic effect: Ø HOMA-IR, Ø OGTT (glucose), Ø HbA1c, Ø 1,5-anhydroglucitol, Ø FBG, Ø FBI, ↓ hyperinsulinemia, ↑ CISI (statistically significant only compared to baseline, no between groups)
Hypolipidemic effect: ↓ TC, ↓ LDL, Ø TG, Ø HDL
[114]
Kochujang (KJ)30Mice12 weeksHFD with KJ (22%)Normal diet, HFDAnti-obesity effect: ↓ BW, ↓ epididymal fat, ↓ back fat, ↑ food intake
Anti-diabetic effect: ↓ glucose
Hypolipidemic effect: ↓ TC, ↓ LDL, Ø HDL
[115]
Kochujang6090% of pancreatectomized diabetic rats8 weeksHFD with KJ (5%) fermented in a traditional method or a modern method (with A. sojae, B. subtilis)Diabetic rats, non-diabetic ratsAnti-obesity effect: ↓ epididymal fat, ↓ leptin, ↑ caloric intake (both groups)
Anti-diabetic effect: ↓ glucose, ↓ insulin, improved OGTT (both groups)
[116]
Kochujang26Hyperlipidemic subjects12 weeksDried KJ fermented with A. oryzae (34.5 g/day)Placebo, baselineHypolipidemic effect: ↓ TC (both compared to baseline and placebo), ↓ LDL (only compared to baseline), Ø HDL, Ø TG[57]
Kochujang53Overweight or obese adults with BMI ≥ 23 kg/m2 or WHR ≥ 0.90 for males or ≥0.85
for females
12 weeksDried KJ (32 g/day)Placebo, baselineAntioxidant effect: Ø ORAC, Ø GSH, ↓ TRAP (compared to baseline), Ø SOD, ↓ CAT
No anti-obesity effect: Ø BMI, Ø WHR, Ø WC, Ø visceral fat, Ø subcutaneous fat
No anti-diabetic effect: Ø glucose, Ø insulin, Ø HOMA-IR, Ø HbA1c
Hypolipidemic effect: Ø TC, Ø LDL, Ø HDL, Ø FFA, ↓ TG (compared to placebo), ↓ ApoA1, ↓ApoB (compared to baseline)
No hypotensive effect: Ø SBP, Ø DBP
[117]
Kochujang48Overweight adults with BMI ≥ 23 kg/m26 weeksFreeze-dried KJ (19 g/day): traditional with a high content of beneficial microorganisms (HTK), or traditional containing a low content of beneficial microorganisms (LTK), or a commercial KJ (CK)BaselineNo anti-inflammatory effect: Ø hs-CRP
Anti-obesity effect: ↓ hip circumference, ↓WHR (only CK group), ↓ visceral fat (only HTK group), ↓ WC (HTK and CK groups)
No anti-diabetic effect: Ø adiponectin, Ø leptin, Ø subcutaneous fat, Ø BMI, Ø BW, Ø body fat (kg), body fat (%), Ø glucose
Hypolipidemic effect: ↓ TC, ↓ LDL, ↓ TG, ↓ HDL (significant only for HTK)
[118]
Doenjang (DJ)24Mice8 weeksHFD with DJ (amount not given)Normal diet, HFDAnti-inflammatory effect: ↓ TNF-α
Anti-obesity effect: ↓ BW, ↓ food efficiency ratio, Ø food intake, Ø epididymal fat, Ø leptin, Ø adiponectin
Hypolipidemic effect: ↓ TG, ↓ FFA, Ø TC, Ø HDL
[119]
Doenjang47Mice11 weeksHFD with steamed soybeans (11.7%) or DJ (14.4%)Low-fat diet, HFDAnti-obesity effect: ↓ BW, ↓ epididymal fat, ↓ leptin (compared to HFD, only for DJ group, not in soybean group), Ø adipocyte size[60]
Doenjang28Mice14 weeksHFD with short-term fermented soybean paste with starter (A. oryzae) (SFSP) or long-term fermented soybean paste (LFSP)Normal diet, HFDAnti-obesity effect: ↓ BW, ↓ subcutaneous fat (only LFSP group)
Anti-diabetic effect: ↑ insulin sensitivity in liver and skeletal muscle (only LFSP group), Ø insulin
Hypolipidemic effect: ↓ TG (only LFSP group), Ø TC
[120]
Doenjang18Rats8 weeksHigh-salt diet (8% NaCl) with freeze-dried DJ (water solution)Normal diet, high-salt diet (8% NaCl)No anti-obesity effect: Ø BW
Hypotensive effect: ↓ SBP, ↓ serum renin
[55]
Doenjang24Rats13 weeksHFD with DJ (containing 8% of salt)Normal diet and HFD, and HFD with 8% saltAnti-obesity effect: ↓ BW, ↓ fat weight/BW, ↓ adipocyte size
Anti-diabetic effect: ↓ glucose (lower than both the normal diet and HFD group)
Hypotensive effect: ↓ SBP, ↓ serum aldosterone, Ø serum renin, Ø serum angiotensin II
[121]
Doenjang51Adults with BMI ≥ 23 kg/m2 or WHR ≥ 0.90 for males or ≥0.85
for females
12 weeksDried DJ (9.9 g/day)Placebo and baselineAnti-obesity effect: ↓ BW, ↓ body fat (kg), ↓ body fat (%), visceral fat (cm2) (compared both to baseline and placebo), ↓ WHR, ↓ total fat (cm2), ↓ subcutaneous fat (compared only to baseline)
Hypolipidemic effect: Ø TG, Ø HDL, Ø FFA
↓ TC, ↓ LDL, ↓ ApoA1, ↓ ApoB (compared only to baseline)
[122]
Conclusions: Fermented caper fruits, kimchi, and DJ are fermented products that may be beneficial in reducing body weight. CGJ and natto appear to be the most well-studied products and are considered potential superfoods for patients with diabetes. Consumption of CGJ has been shown to reduce blood glucose levels, improve OGTT results, and positively affect β-cell function. Tempeh consumption has been associated with reductions in blood glucose levels and HbA1c in both human and animal models. The lipid profile may be improved following the consumption of fermented soybean products, including tempeh, natto, and KJ. To the best of our knowledge, there are no studies evaluating the effects of table olives and sauerkraut consumption on metabolic parameters in either animal or human models.
1 Ø, no effect; ↓, decrease; ↑, increase; information about statistical significance is given in parentheses and refers to all the parameters listed earlier for a given health effect. AC sugar, fasting blood sugar; Apo A1, apolipoprotein A1; Apo B, apolipoprotein B; BW, body weight; CAT, catalase; CISI, Composite Insulin Sensitivity Index; DI, Disposition Index; FBG, fasting blood glucose; FBI, fasting blood insulin; HC, hip circumference; HFD, high-fat diet; IGI, insulinogenic index; MCP-1, monocyte chemoattractant protein-1; QUICKI, Quantitative Insulin Sensitivity Check Index; SF, subcutaneous fat; SOD, superoxide dismutase; TAC, total antioxidant status; TRAP, plasma total radical-trapping antioxidant; V/S, visceral fat/subcutaneous fat ratio; VF, visceral fat; WC, waist circumference; WHR, waist/hip ratio.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Bernacka, K.; Sozański, T.; Kucharska, A.Z. Fermented Fruits, Vegetables, and Legumes in Metabolic Syndrome: From Traditional Use to Functional Foods and Medical Applications. Nutrients 2025, 17, 1989. https://doi.org/10.3390/nu17121989

AMA Style

Bernacka K, Sozański T, Kucharska AZ. Fermented Fruits, Vegetables, and Legumes in Metabolic Syndrome: From Traditional Use to Functional Foods and Medical Applications. Nutrients. 2025; 17(12):1989. https://doi.org/10.3390/nu17121989

Chicago/Turabian Style

Bernacka, Karolina, Tomasz Sozański, and Alicja Z. Kucharska. 2025. "Fermented Fruits, Vegetables, and Legumes in Metabolic Syndrome: From Traditional Use to Functional Foods and Medical Applications" Nutrients 17, no. 12: 1989. https://doi.org/10.3390/nu17121989

APA Style

Bernacka, K., Sozański, T., & Kucharska, A. Z. (2025). Fermented Fruits, Vegetables, and Legumes in Metabolic Syndrome: From Traditional Use to Functional Foods and Medical Applications. Nutrients, 17(12), 1989. https://doi.org/10.3390/nu17121989

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop